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Abstract 
 Skeletal muscle is a unique tissue composed of multinucleated, post-mitotic fibers. 
Despite its post-mitotic nature, skeletal muscle has an astounding ability to regenerate after 
injury largely thanks to muscle-specific stem cells known as satellite cells. Skeletal muscle also 
constantly balances rates of protein synthesis and breakdown in order to maintain its viability. 
One of the major systems involved in muscle protein degradation is autophagy. During 
autophagy, long-lived and damaged cellular components are sequestered in double membrane 
bound vesicles known as autophagosomes and are subsequently degraded by lysosomes. The E1-
like enzyme known as ATG7 (autophagy-related protein 7) is critical to this process as it plays a 
key role in autophagosome formation. Autophagy has important metabolic functions, but it also 
plays a major role in cell quality control in order to reduce cell stress and a form of cell death 
known as apoptosis. Apoptosis can be induced by a number of internal and/or external signals, 
and leads to the cleavage of a variety of different proteins within the cell. Many points of 
interaction exist between apoptosis and autophagy which has led to increased examination of the 
interplay between the two processes. Conclusions from these studies have caused a divergence in 
opinion regarding the protective or toxic role of autophagy in times of stress in various tissues, 
including skeletal muscle. Consequently, the aim of the current thesis was to investigate the role 
of autophagy in modulating apoptotic signaling and skeletal muscle recovery in response to 
cardiotoxin-induced muscle damage. To do this, tamoxifen-inducible, skeletal muscle-specific 
Atg7 knockdown mice (i.e. F/F
Cre
 mice) generated using Cre-lox technology were compared to 
control mice (i.e. F/F mice) prior to and 3, 7, and 14 days after cardiotoxin-induced skeletal 
muscle injury. This model was shown to be quite effective in knocking down the Atg7 gene, as 
ATG7 protein was reduced by ~61% in the F/F
Cre
 mice relative to the F/F control mice prior to 
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cardiotoxin exposure. Unexpectedly, a restoration of ATG7 expression was observed in the 
F/F
Cre
 mice by day 3 post-injury. It is speculated that this return of ATG7 protein was caused by 
the recruitment of satellite cells to the muscle fibers in response to damage, as the induction of 
Atg7 knockdown likely did not occur in these cells. It is also possible that Cre-mediated 
recombination of Atg7 did not occur in all of the myonuclei, and in turn, Atg7
+/+
 myonuclei 
could have upregulated ATG7 production after cardiotoxin exposure. Although the restoration of 
ATG7 in the F/F
Cre
 mice prevented the current study from examining changes in apoptotic 
signaling and muscle recovery in response to autophagy inhibition, it was still possible to 
examine the relationship between autophagy and apoptosis in response to acute muscle damage. 
Autophagic signaling appeared to peak on day 3 post-cardiotoxin injury and then began to 
decrease over time. In contrast, apoptotic signaling was only slightly elevated on day 3, and did 
not peak until day 7 when autophagic activity was decreasing. These findings, in combination 
with reduced cytochrome c, MnSOD, and CuZnSOD on day 3, as well as reduced tBid 
expression on day 3 and 7, may suggest that autophagy plays a cytoprotective role after muscle 
damage by suppressing cell stress and apoptotic signaling. Additionally, the results of the current 
study suggest that basal autophagy inhibition could potentially alter fiber type distribution and 
cause reductions in muscle mass, while a subsequent restoration of autophagy could return 
muscle fiber type composition and muscle mass to control levels. Overall, this thesis was able to 
further elucidate the temporal relationship between autophagic and apoptotic signaling after 
acute muscle injury, and was able to evaluate the effects of basal autophagy inhibition on muscle 
mass and muscle fiber type distribution. Valuable methodological information for future studies 
planning to use inducible, skeletal muscle-specific gene knockout models in conditions of 
extensive muscle damage can also be drawn from the results of this thesis.  
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Introduction 
Skeletal muscle 
Skeletal muscle is a highly metabolically active tissue that constitutes 40-50% of total 
body mass
1
. It is a unique tissue composed of multinucleated, post-mitotic fibers that functions to 
facilitate movement, breathing, and control of posture
2
. Contraction of skeletal muscle can cause 
tissue damage that needs to be repaired in order for the muscle to function optimally
3
. 
Interestingly, despite its post-mitotic nature, skeletal muscle possesses an astounding ability to 
regenerate itself in response muscle damage
4
. 
The regeneration of skeletal muscle is facilitated by a specialized population of muscle 
stem cells known as satellite cells (SCs)
5
. These cells are located between the sarcolemma and 
the basal lamina of muscle fibers, and remain quiescent under normal conditions
5
. However, 
satellite cells can become activated and begin to proliferate in response to muscle injury
5
. It is 
believed that this activation is caused in part by decreased inhibitory signals due to the 
destruction of the satellite cell niche, and due to the production of activating factors at the basal 
lamina
5
. Once activated, satellite cells are able to proliferate, differentiate, and fuse with one 
another to create new myofibers, or fuse to existing fibers to provide them with myonuclei to 
support regeneration
6
. Furthermore, these cells have the ability to self-renew, as some of the 
proliferating satellite cells will return to the satellite cell compartment and once again become 
quiescent
5
. This feature provides skeletal muscle with the ability to deal with degeneration and 
injury throughout the life cycle
5
.     
Another important feature of skeletal muscle is its ability to balance rates of protein 
anabolism and catabolism in order to create a level of protein turnover that maintains the tissue’s 
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viability, mass, and function
7
. Protein synthesis is required to maintain a homeostatic 
environment as it allows for the production of various cellular components
8
, while protein 
degradation is equally important in order to remove long-lived and damaged proteins and reduce 
cell stress
8, 9
. In muscle, the two major proteolytic systems are the ubiquitin-proteasome system 
and autophagy
10
. 
The ubiquitin-proteasome system and autophagy 
 The ubiquitin-proteasome system (UPS) degrades proteins through the multi-enzyme 
complex known as the proteasome
11
. However, in order for this degradation to occur, proteins 
must first be tagged for destruction via covalent attachment of polyubiquitin chains by E3 
ubiquitin ligase enzymes
11
. Although a large number of E3 ligases exist, two that are particularly 
important in skeletal muscle are muscle atrophy F-box (MAFbx/atrogin-1) and muscle RING 
finger 1 (MuRF1)
11, 12
. Both of these enzymes have been shown to be increased in conditions of 
muscle atrophy
13
. 
Autophagy is a highly regulated, catabolic process that is vital for tissue homeostasis
14
. 
During this process, an isolation membrane, otherwise known as a “phagophore”, elongates 
within the cytoplasm and sequesters cellular components (e.g. proteins, organelles) before 
maturing into a double membrane bound vesicle known as an autophagosome
14
. The 
autophagosome then fuses with a lysosome resulting in the formation of an autophagolysosome. 
Lysosomal enzymes then degrade the cellular components isolated within the autophagosome
14
. 
A unique feature of autophagy is that the process contains two ubiquitin-like conjugation 
systems that facilitate elongation of the phagophore
15
. Autophagy-related (ATG) proteins play a 
large role in both of these systems. The first system involves the formation of a complex 
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containing ATG12, ATG5, and ATG16. In this system, the E1-like enzyme ATG7 binds to and 
activates ATG12, which is then transferred to the E2-like enzyme ATG10 and is finally 
conjugated with ATG5. The ATG12- ATG5 conjugate then associates with ATG16 to form the 
ATG12-ATG5-ATG16 complex
15
. In the second system, a protein known as LC3 is first 
synthesized as pro-LC3 and is then processed by ATG4 into LC3-I, the cytosolic form of the 
protein. LC3-I is then activated by the E1-like enzyme ATG7, passed on to the E2-like enzyme 
ATG3, and then is conjugated to phosphatidylethanolamine with the aid of the ATG12-ATG5-
ATG16 complex (which acts as an E3-like enzyme of LC3). This results in the formation of the 
autophagosomal membrane-bound form of LC3 known as LC3-II
15
. Dysfunction in either of 
these systems can disrupt the autophagic response as they are both essential for autophagosome 
formation
16
. For example, disruption of the Atg7 gene results in an inhibition of LC3-I 
conjugation, impaired autophagosome formation, and autophagy suppression
17-21
.  
  One of the fundamental functions of autophagy is to mobilize substrates for ATP 
production during times of nutrient deficiency (i.e. starvation)
22
. A study by Lum and colleagues 
helped to solidify this starvation-induced role. This group demonstrated that IL-3 dependent cells 
that were unable to take in sufficient nutrients due to IL-3 withdrawal were able to maintain their 
ATP production and viability for a period of time by upregulating autophagy
23
. Although it was 
originally believed that autophagy only supported ATP production through breakdown of 
proteins into amino acids, recent research has shown that autophagy is also able to produce 
metabolic substrates by breaking down carbohydrates and lipids
24
. In addition to providing 
metabolic substrates, autophagy also helps to maintain cell viability during times of starvation by 
using mobilized amino acids to synthesize proteins which help the cell adapt to the starvation 
environment
25
. 
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Along with its metabolic function, autophagy is also involved in cell quality control
26
. 
Basal autophagy facilitates the degradation of long-lived cytoplasmic contents and damaged 
organelles and proteins
26
. Accumulation of these damaged cellular products leads to cytotoxic 
effects, and in turn, the turnover and removal of these products by autophagy helps to decrease 
stress signaling and prevent cell death processes, including a form of cell death known as 
apoptosis
27
.  
Apoptosis 
Apoptosis is a highly controlled form of cell death that is important in tissue development 
and homeostasis
28
. This form of cell death is regulated by a family of cysteine proteases known 
as caspases, which have been shown to play an essential role in both the initiation and execution 
of apoptosis
29
. These proteases are involved in a signaling cascade in which a variety of protein 
substrates are cleaved which leads to the eventual induction of apoptotic cell death
30
. Activation 
of this signaling cascade can occur in response to both internal and external signals
29
. The main 
pathway leading to caspase-dependent apoptosis is known as the mitochondrial stress pathway. 
This pathway is characterized by mitochondrial outer membrane permeabilization (MOMP) as a 
result of pore formation in the outer mitochondrial membrane
31
. This pore formation is regulated 
by pro- and anti-apoptotic members of the Bcl-2 family of proteins, which can be subdivided 
based on the number of Bcl-2 homology (BH) domains that these proteins contain
31
. The anti-
apoptotic proteins in this family (e.g. Bcl-2, Bcl-xL) contain all four BH domains (i.e. BH1-
BH4), while the pro-apoptotic proteins contain 2-3 BH domains (e.g. the multidomain proteins 
Bax and Bak) or contain only the BH3 domain (e.g. the BH3-only proteins Bid and Bim)
31
. In 
response to apoptotic signals, pro-apoptotic Bcl-2 family proteins insert themselves into the outer 
mitochondrial membrane and form pores
31
. This leads to the release of pro-apoptotic factors like 
  
5 
 
cytochrome c into the cytosol, resulting in the activation of caspase-9 which then cleaves and 
activates caspase-3; a critical enzyme in promoting cell death
32
.  Anti-apoptotic proteins such as 
Bcl-2 and Bcl-xL can inhibit this pore formation, cytochrome c release, and subsequent 
apoptosis by inhibiting the pro-apoptotic proteins at the level of the mitochondria
33
. The 
endoplasmic reticulum (ER) stress pathway is another internal apoptotic pathway that leads to an 
accumulation of damaged proteins which causes endoplasmic reticulum stress. This results in the 
activation of calpains, caspase-12, and eventually caspase-3 causing apoptosis
34
. Finally, in the 
externally stimulated death receptor pathway, ligands in the extracellular space such as TNF-α 
and FasL bind to their respective receptors located on the plasma membrane which leads to 
caspase-8 and caspase-3 activation, and ultimately apoptosis
34
. 
In addition to caspase-dependent apoptosis, there are also caspase-independent forms of 
apoptosis initiated at the mitochondria. During caspase-independent apoptosis, pore formation in 
the mitochondria leads to the release of molecules such as apoptosis-inducing factor (AIF) and 
endonuclease G (EndoG) into the cytosol
34
. These molecules then translocate to the nucleus and 
directly cause DNA fragmentation, resulting in apoptotic cell death
34
. 
Points of interaction between autophagy and apoptosis 
Despite different signaling and seemingly different roles, several points of interaction 
exist between the autophagic and apoptotic pathways
33
. Beclin-1 is a key example of this 
interplay. Beclin-1 is one of the proteins, along with Vps34, Vps15, and potentially Ambra1, that 
is incorporated into the Beclin-1 core complex
35
. The formation of this complex is essential for 
autophagy as it activates the phosphatidylinositide 3-kinase (PI3K) Vps34, which produces 
phosphatidylinositol-3-phosphate (PI3P)
35
. The production of this phospholipid molecule is 
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important as it recruits a variety of proteins that facilitate the preliminary steps of 
autophagosome formation (i.e. upstream of the conjugation systems mentioned above)
15
.  As 
discussed earlier, Bcl-2 and Bcl-xL are both examples of anti-apoptotic proteins, however, these 
two proteins also possess anti-autophagic properties as they contain BH3-binding grooves which 
can interact with the BH3 domain of Beclin-1 and inhibit autophagy
33
. In order to activate 
Beclin-1-mediated autophagy, the Bcl-2/Bcl-xL-Beclin-1 complex must be dissociated, which 
can be accomplished by different mechanisms including competition for Bcl-2 binding by pro-
apoptotic proteins with BH3 binding domains (e.g. Bid, Bad),  c-Jun N-terminal kinase-1 (JNK1) 
phosphorylation of Bcl-2, or death-associated protein kinase (DAPK) phosphorylation of the 
BH3 domain of Beclin-1
15
. Beclin-1 also displays its dual roles in both autophagy and apoptosis 
as upon cleavage by caspases, Beclin-1 loses its autophagic potential and becomes a pro-
apoptotic molecule that translocates to the mitochondria and facilitates cytochrome c release and 
caspase activation
36
. 
ATG5 is another protein that can play a role in both autophagic and apoptotic signaling. 
ATG5 is involved in the ATG12-ATG5-ATG16 complex which is vital for the formation of the 
autophagosome
37
. Additionally, research has shown that ATG5 can associate with Fas associated 
protein with death domain (FADD) and stimulate caspase-dependent apoptosis via the death 
receptor signaling pathway
38
. ATG5 is also associated with apoptosis as cleavage of ATG5 by 
calpains has been shown to lead to the translocation of cleaved ATG5 to the mitochondria where 
it interacts with Bcl-xL and causes pore formation, cytochrome c release, and subsequent caspase 
activation
39
. Similarly, ATG4D is a protein involved in the LC3 conjugation system, which upon 
cleavage by caspases will delipidate the LC3 homologue GABARAP-L1 causing a decrease in 
the number of GABARAP-L1 autophagosomes
33
. It has also been shown that caspase-cleaved 
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ATG4D translocates to the mitochondria, and that mitochondrial ATG4D increases the cells 
susceptibility to death, although the exact mechanism through which mitochondrial ATG4D 
contributes to cell death is unknown
40
. The role of ATG4D in cell death is further complicated 
by the fact that cleaved ATG4D localization to the mitochondria can be seen even in cells treated 
with caspase inhibitors, demonstrating that a pathway involving caspase-independent cleavage of 
ATG4D must also exist
40
. 
The interaction between autophagy and apoptosis can also be seen in cancer cells. In 
these cells, apoptotic pathways are usually impaired while autophagic pathways remain intact, 
leading to increased survival of these cells
41
.  One mechanism responsible for this increased 
survival is the ability of autophagy to regulate apoptosis. In cancer cells known to be resistant to 
tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis (i.e. death 
receptor mediated apoptosis), caspase-8 is isolated within autophagosomes and then degraded by 
lysosomes, showing the ability of autophagy to inhibit apoptosis
41
.  
Clearly there is a considerable amount of interplay between the autophagic and apoptotic 
pathways. Further investigation of this interplay is warranted to better understand how these 
pathways regulate one another. 
Apoptosis in skeletal muscle 
Because of its unique multinucleated structure, skeletal muscle apoptosis is believed to 
occur differently than in mononucleated cells. While apoptosis normally results in death of the 
entire mononucleated cell, skeletal muscle is thought to undergo a specialized form of apoptosis 
known as “nuclear apoptosis”. During nuclear apoptosis, individual nuclei are said to be 
eliminated from the muscle fiber rather than death of the entire cell
42
. However, the idea of 
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nuclear apoptosis has been contested as of late as some studies have shown no myonuclear loss 
during skeletal muscle atrophy
43, 44
. Nevertheless, caspase and calpain activation in skeletal 
muscle can lead to cleavage of several muscle-specific substrates, resulting in atrophy and 
contractile dysfunction
45-47
. This suggests that nuclear apoptosis is not the only critical aspect of 
apoptotic signaling to consider in muscle pathogenesis. 
Although apoptosis has been shown to be essential in the maintenance of mitotic cells, 
the role of apoptosis in post-mitotic tissues like skeletal muscle is less well understood
29
. 
Apoptotic signaling has been shown to be crucial in muscle differentiation, as the inhibition or 
deletion of caspase-3 in muscle cells causes a striking decrease in muscle fiber formation
48
. 
Conversely, apoptosis can also have detrimental effects in skeletal muscle. Increases in apoptosis 
along with muscle atrophy have been observed during immobilization, denervation, aging, and 
chronic heart failure
45, 49-51
. Skeletal muscle apoptosis is also initially increased after blunt crush 
injury, but eventually returns to basal levels
52
. Interestingly, suppressing apoptosis via caspase 
inhibition after this same blunt crush injury results in a faster restoration of muscle function
53
. 
Clearly, more research is needed to better understand the role of apoptosis in skeletal muscle 
homeostasis. 
Autophagy in skeletal muscle 
Nutrient deprivation is known to be a strong stimulator of autophagy in skeletal muscle
15
. 
However, there are also a variety of other stresses that can activate autophagy, including 
hypoxia, denervation, ER stress, oxidative stress, and mitochondrial damage
15
. In the absence of 
autophagy, increases in mitochondrial dysfunction, reactive oxygen species (ROS), ER stress, 
and atrophy-related gene expression (e.g. MurF-1, atrogin-1) have been observed, along with the 
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accumulation of ubiquitinated proteins and abnormal mitochondria
17, 54, 55
.  Importantly, 
inhibition of autophagy has also been shown to cause DNA fragmentation, skeletal muscle 
atrophy, and decreased force production
17, 56
. These findings seem to suggest that autophagy 
plays a protective role in skeletal muscle homeostasis. However, other studies in skeletal muscle 
provide conflicting evidence regarding this topic. For example, increases in autophagy in 
combination with increased DNA fragmentation and muscle atrophy have been shown during 
muscle denervation
57
. Additionally, an upregulation of autophagy and DNA fragmentation has 
been observed in skeletal muscle after the injection of doxorubicin, a myotoxic drug
58
. A study 
by Mammucari and colleagues also found an upregulation of autophagy and muscle atrophy in 
mice expressing a constitutively active form of FoxO3 (i.e. a transcription factor that is necessary 
and sufficient to cause autophagy activation)
10
. Finally, a large increase in autophagy along with 
muscle weakness and premature death is observed during Pompe disease
56
. Due to these 
contradictory findings regarding the cytoprotective or cytotoxic role of autophagy, a more 
thorough investigation of autophagy in skeletal muscle is warranted.  
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Purpose 
 Because of the controversial role of autophagy in the protection against or induction of 
cell death mechanisms, it would be beneficial to examine the relationship between autophagic 
and apoptotic processes in greater detail. Specifically, due to the cell’s ability to respond to 
various stresses by inducing autophagy, it is of interest to examine this relationship in skeletal 
muscle following muscle injury. To date, no research has examined if autophagy is directly 
involved in skeletal muscle damage and apoptosis, or if autophagy is required for skeletal muscle 
recovery after injury. Therefore, the purposes of this Master’s thesis project were:  
1) to examine the role of autophagy in modulating apoptotic signaling following cardiotoxin-
induced skeletal muscle injury, and  
2) to investigate the role of autophagy in skeletal muscle recovery after cardiotoxin-induced 
muscle damage.  
To accomplish this, male skeletal muscle-specific inducible Atg7 knockdown (i.e. 
autophagy deficient) and wild-type control mice were studied.  
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Hypotheses 
It was hypothesized that: 
1)  a post-developmental inhibition of autophagy will cause a greater increase in the 
initial apoptotic signaling in the skeletal muscle of the Atg7 knockdown compared to control 
mice in response to cardiotoxin-induced muscle damage (See Figure 1), 
2) apoptotic signaling will remain elevated for a prolonged period of time during 
recovery in the Atg7 knockdown mice (See Figure 1), and 
3) a reduction in muscle regeneration will be observed in the Atg7 knockdown mice as 
evidenced by a greater difference in fiber cross-sectional area between day 0 and day 14 in the 
Atg7 knockdown mice compared  to control mice (See Figure 2). Additionally, it is hypothesized 
that the proportion of the muscle containing damaged and/or centrally nucleated (i.e. 
regenerating) fibers will be elevated in the knockdown animals relative to the control animals on 
day 14. 
 
Figure 1: Visual representation of hypothesis 1 and 2. The response observed between day 0 and day 3 was 
considered the “muscle damage” phase, while the response seen on day 7 and day 14 was considered the “muscle 
recovery” phase. 
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Figure 2: Visual representation of hypothesis 3. 
 
It was hypothesized that these changes would occur because upon muscle injury, a 
variety of organelles and proteins would become damaged and would accumulate due to a lack 
of autophagy in the Atg7 knockdown mice. This accumulation would lead to further damage, 
activation of apoptotic signaling, and fiber atrophy. These changes would provide support for the 
idea that autophagy serves a cytoprotective role in skeletal muscle and would further elucidate 
the relationship between autophagy and apoptosis. 
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Methods 
Animals 
 The animals used in this study were generated by first breeding Atg7 F/F mice (kindly 
donated by Herbert Virgin, Washington University)
18
 with HSA-MerCreMer
 
mice (kindly 
donated by Karyn Esser, University of Kentucky)
59
. The Atg7 F/F animals contain Atg7 genes 
that are flanked by LoxP sites (i.e. floxed) on both chromosomes, meaning they are homozygous 
for the “floxed” gene. These LoxP sites are specific 34 base pair sequences that must be inserted 
into the mouse genome through transgenic technology as they are not normally found in mouse 
DNA
60
. The HSA-MerCreMer animals express the wild-type (WT) Atg7 gene on both 
chromosomes (i.e. rather than the “floxed” Atg7gene), but are also hemizygous for the Cre 
recombinase (Cre) gene. The importance of the Cre gene is that when it is transcribed and 
translated to form the Cre recombinase enzyme, and this enzyme is present in the nucleus, it is 
able to recognize and bind to LoxP sites
60
. The enzyme then catalyzes the recombination of the 
genes between the LoxP sites, rendering these genes useless
60
. In turn, if an animal expresses 
floxed Atg7 genes, and Cre recombinase is present in the nucleus, the Atg7 genes will be 
removed resulting in the production of Atg7 knockdown mice. Due to the important role of 
ATG7 in autophagosome formation, knocking out this gene will produce mice that are autophagy 
deficient. In our model, the Cre gene is surrounded by two mutated estrogen receptor (Mer) 
ligand binding domains that have a 1000-fold lower affinity to estrogen
61, 62
, yet maintain their 
affinity for the synthetic compound 4-hydroxytamoxifen (herein referred to simply as 
tamoxifen). This gene complex is also connected to the promoter and first exon of the human α-
skeletal actin (HSA) gene, thereby regulating Cre expression in a skeletal muscle-specific 
manner
63
.   
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Although the Mutated estrogen receptor-Cre recombinase-Mutated estrogen receptor 
(MerCreMer) protein complex is transcribed whenever the HSA promoter is activated, this 
model is considered inducible because in the absence of tamoxifen, this complex remains in the 
cytosol. In turn, the Cre recombinase enzyme does not have access to the LoxP sites surrounding 
the Atg7 genes and the genes remain intact
64, 65
. However, when animals that express the Cre 
gene as well as floxed Atg7 genes are injected with tamoxifen, the tamoxifen will bind to the 
Mer ligand binding domains and cause a translocation of the MerCreMer complex into the 
nucleus
64, 65
. Once in the nucleus, Cre recombinase will bind to the LoxP sites and cause 
recombination of the Atg7 genes
64, 65
.  
The offspring produced by crossing the Atg7 F/F and HSA-MerCreMer mice were either 
Atg7 F/WT or Atg7 F/WT
Cre 
. The Atg7 F/WT
Cre 
mice were then used in the next breeding step, 
where they were bred back to the Atg7 F/F mice. This resulted in the birth of 4 different groups 
of mice: Atg7 F/WT mice which were sacrificed, Atg7 F/WT
Cre
 mice which were used for 
subsequent breeding, Atg7 F/F mice which were used as control animals, and Atg7 F/F
Cre
 mice 
which were used as the inducible Atg7 knockdown mice.  
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Figure 3: Breeding diagram. The Atg7 F/F
Cre
 mice produced by crossing the Atg7 F/F and Atg7 F/Wt
Cre
 in the 
second breeding step were used as the experimental mice (i.e. as the inducible Atg7 knockdown mice), while the 
Atg7 F/F mice produced from the same breeding combination were used as the control mice. 
 
Experimental design 
First, Atg7 F/F
Cre
 mice were given intraperitoneal injections of tamoxifen (Atg7 
F/F
Cre
+Tam) for 5 consecutive days in order to stimulate transcription of the Cre recombinase 
enzyme to promote Atg7 knockdown. Atg7 F/F mice were also injected with tamoxifen at this 
time point (Atg7 F/F+Tam). After a 2-week period to allow for significant Atg7 knockdown in 
the Atg7 F/F
Cre
+Tam animals
66
 (pilot studies revealed a reduction of ~55-70% in soleus and 
plantaris ATG7 protein, while no reduction was seen in heart or liver; Appendix figure A1), 
these mice received intramuscular injections of cardiotoxin (CTX) into the tibialis anterior,  as 
well as both heads of the gastrocnemius on both legs (i.e. 3 injections per leg, 6 injections total) 
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(Atg7 F/F
Cre
+Tam+CTX). The Atg7 F/F mice were also injected with CTX at this point in time 
(Atg7 F/F+Tam+CTX). Cardiotoxin injections were performed to allow us to examine the 
physiological response to muscle injury as CTX is a myotoxic compound that induces rapid 
muscle fiber depolarization and contraction that leads to plasma membrane disruption and fiber 
lysis
2
. Ultimately, this experimental design produced 2 groups:  
Group 1= Atg7 F/F
Cre
+Tam+CTX 
Group 2 = Atg7 F/F+Tam+CTX 
  Animals from each group were sacrificed 0, 3, 7, and 14 days after cardiotoxin injection 
(Note: day 0 animals were sacrificed after the 2 week washout period without receiving 
cardiotoxin injections). These time points were chosen to allow us to examine various cellular 
features prior to muscle injury (i.e. day 0), during the inflammatory phase of injury (i.e. day 3), 
during the muscle fiber regeneration phase (i.e. day 7), and after the muscle had regenerated 
intact fibers and regained a relatively normal muscle architecture (i.e. day 14)
2
. Autophagic, 
apoptotic, and morphological data was collected using immunoblotting, caspase, calpain, 
cathepsin, and proteasome activity assays, ROS production assays, immunohistochemical fiber 
type staining, and hematoxylin and eosin (H & E) staining. 
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Figure 4: Experimental design. Both the F/F and F/F
Cre
 mice received tamoxifen injections for 5 consecutive days. 
This injection period was followed by a 2 week period to allow for gene knockdown. After this, some mice from 
both groups were sacrificed and classified as day 0 mice, while additional animals received intramuscular injections 
of cardiotoxin. Animals from both the F/F and F/F
Cre
 groups were sacrificed 3, 7, and 14 days post-cardiotoxin 
injections. 
 
Tamoxifen and cardiotoxin injections 
Nine to twelve week old Atg7 F/F and Atg7 F/F
Cre
 mice were injected (i.e. via 
intraperitoneal injection) with 2 mg of tamoxifen dissolved in sunflower seed oil (10mg/mL) 
daily for 5 days. Pilot data was collected to ensure that this dose effectively knocked down the 
Atg7 gene in the Atg7 F/F
Cre
 mice (Appendix Figure A1).  
After a 2 week period to allow for significant recombination of the Atg7 gene, the Atg7 
F/F and Atg7 F/F
Cre
 animals that were injected with tamoxifen were anaesthetized using 
isoflurane and given a 50µL intramuscular injection of 10µM cardiotoxin (Naja mossambica 
mossambica; Sigma-Aldrich, product #: C9759) into the tibialis anterior, and a 75µL injection 
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into each head of the gastrocnemius in both legs (i.e. 3 cardiotoxin injections per leg, 6 total). All 
mice received a 60 µL subcutaneous injection of meloxicam (i.e. a non-steroidal anti-
inflammatory drug with analgesic effects) immediately after and 24 hours post-cardiotoxin 
treatment. 
Muscle extraction and sample preparation 
Mice were sacrificed by cervical dislocation at day 0 (i.e. prior to cardiotoxin injection), 
and 3, 7, and 14 days after cardiotoxin injection. The tibialis anterior (TA) was extracted from 
both legs: one was frozen in liquid nitrogen, while a sample of the entire circumference from the 
middle portion of the other TA was embedded in Optimal Cutting Temperature (OCT) 
compound (Tissue-Tek) and frozen in liquid nitrogen-cooled isopentane. These samples were 
then stored at -80°C. The gastrocnemius was also removed from each leg and was first separated 
into its two heads, and then each head was separated in half with equal portions of red and white 
gastrocnemius. These muscle samples were then frozen in liquid nitrogen by freeze clamping and 
stored at -80°C. Lastly, soleus and plantaris muscles were extracted at all time points, and 
quadriceps muscle was isolated on day 14. These muscles were frozen in liquid nitrogen and 
stored at -80°C.  
Gastrocnemius and quadriceps muscle samples to be used for immunoblotting were 
homogenized in ice-cold lysis buffer (20mM HEPES, 10mM NaCl, 1.5mM MgCl2, 1mM DTT, 
20% glycerol and 0.1% Triton X-100; pH 7.4) that included protease inhibitors (Complete 
Cocktail; Roche Diagnostics) using a handheld glass homogenizer. Gastrocnemius muscle 
samples to be used for caspase, calpain, cathepsin, and proteasome activity assays were 
homogenized in a similar manner in the absence of protease inhibitors. Homogenates were 
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centrifuged at 1000g for 10 minutes at 4°C and the supernatants were collected and stored at -
80°C. Protein concentration of the supernatants was determined by BCA protein assay.  
Immunoblot analyses 
For immunoblotting, equal amounts of protein from gastrocnemius homogenates were 
loaded into 12% SDS-PAGE gels and separated by electrophoresis. Proteins were transferred 
onto PVDF membranes (BioRad) which were then blocked at 4°C overnight or at room 
temperature for 1 hour using 5% (w/v) milk-TBST. Blocked membranes were incubated in 
primary antibody at 4°C overnight or at room temperature for 1 hour.  After primary antibody 
incubation, the membranes were washed with TBST and incubated with an appropriate 
horseradish peroxidise-conjugated secondary antibody (Santa Cruz Biotechnology) at room 
temperature for 1 hour. The proteins were then imaged using Clarityᵀᴹ Western ECL Substrate 
(BioRad) or ECL Western Blot Substrate (BioVision) and the ChemiGenius 2 Bio-Imaging 
System (Syngene). The optical densities of the imaged bands were analyzed using GeneTools 
software (Syngene). A standard muscle sample of known protein concentration was also loaded 
into each SDS-PAGE gel to allow for normalization of the results. Finally, to guarantee equal 
protein loading and quality of protein transfer, membranes were stained with Ponceau S (Sigma-
Aldrich). 
Immunoblots were conducted with primary antibodies against ATG7 (1:500; product #: 
8558), LC3B (1:500; product #: 2775), Beclin-1 (1:1000; product #: 3738), ATG4B (1:1000; 
product #: 5299) [Cell Signaling], p62 (1:500; product #: GP62-N) [Progen], Hsp70 (1:2000; 
product #: ADI-SPA-810), XIAP (1:1000; product #: ALX-210-327), MnSOD (1:7500; product 
#: ADI-SOD-110), CuZnSOD (1:2000; product #: ADI-SOD-101) [Enzo Life Sciences], catalase 
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(1:2000; product #: 219010) [EMD Millipore], cytochrome c (1:2000; product #: sc-13156), Bcl-
2 (1:200; product #: sc-7382), Bax (1:1000; product #: sc-493), Bid (1:500; product #: sc-11423), 
MAFbx (1:200; product #: sc-33782), and MuRF1 (1:200; product #: sc-32920) [Santa Cruz 
Biotechnology]. 
Caspase and calpain enzyme activity 
The activity of caspase-3, caspase-8, and caspase-9 in gastrocnemius muscle 
homogenates was measured using the substrates Ac-DEVD-AFC (Enzo Life Sciences, product #: 
ALX-260-032), Ac-IETD-AMC (Sigma-Aldrich, product #: A4188), and Ac-LEHD-AMC (Enzo 
Life Sciences, product#: ALX-260-080), respectively. In their pro form, these substrates emit 
only low levels of fluorescence, but upon proteolytic cleavage by their respective active caspase 
enzyme they produce highly fluorescent products
67
. Muscle samples were incubated (in 
duplicate) in assay buffer (20mM HEPES, 10% glycerol, 10mM DTT) with Ac-DEVD-AFC, 
Ac-IETD-AMC, or Ac-LEHD-AMC at room temperature for 2 hours in black 96-well plates. A 
Synergy H1 multi-mode microplate reader (Biotek) was then used to measure fluorescence with 
excitation and emission wavelengths of 360 nm and 440 nm, respectively. Enzyme activity of 
caspase-3, caspase-8, and caspase-9 was normalized to total protein content and the fluorescence 
intensity was expressed in arbitrary units per milligram protein. 
For calpain activity, gastrocnemius samples were incubated in duplicate at 30˚C for 2 
hours in assay buffer (20mM HEPES, 10% glycerol, 10mM DTT) with Suc-LLVY-AMC (Enzo 
Life Sciences, product #: BML-P802) in black 96-well plates. One additional well also contained 
the homogenate, Suc-LLVY-AMC, and the calpain inhibitor Z-LL-CHO (Enzo Life Sciences). A 
Synergy H1 multi-mode microplate reader (Biotek) was used to measure fluorescence with 
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excitation and emission wavelengths of 360 nm and 440 nm, respectively. Calpain activity was 
calculated by subtracting the fluorescence of the well with the inhibitor from the average 
fluorescence of the wells without the inhibitor. This value was then normalized to total protein 
content and expressed as fluorescence intensity in arbitrary units per milligram protein. 
Cathepsin activity 
Activity of lysosomal enzymes was measured through the use of the fluorogenic substrate 
z-FR-AFC (Enzo Life Sciences, product #: ALX-260-129), which is considered to indicate 
cathepsin L and B activities
68, 69
. Gastrocnemius homogenates were loaded into assay buffer (50 
mM sodium acetate, 8 mM DTT, 4 mM EDTA, 1 mM Pefabloc; pH 5.0) in duplicate in black 
96-well plates. The z-FR-AFC substrate was then added to produce an in-well concentration of 
50 µM, and the plate was warmed at 30°C for 5 minutes. To measure fluorescence, a Synergy H1 
multi-mode microplate reader (Biotek) was used with excitation and emission wavelengths of 
400 nm and 505 nm, respectively, for 30 minutes at 30°C. Cathepsin activity was normalized to 
total protein content and expressed as fluorescence intensity in arbitrary units per milligram of 
protein. 
Proteasome activity 
The fluorogenic substrate Suc-LLVY-AMC (Enzo Life Sciences, product #: BML-P802) 
was used to examine chymotrypsin-like activity of the proteasome
70
. Gastrocnemius samples 
were incubated in assay buffer (50 mM Tris/HCl, 25 mM KCl, 10 mM NaCl, 1 mM MgCl2; pH 
7.5) in the dark at 30°C for 1 hour with substrate, or with a combination of substrate and the 
proteasome inhibitor epoxomicin (Cayman Chemical, product #: 10007806) in black 96-well 
plates. Fluorescence was measured using a Synergy H1 multi-mode microplate reader (Biotek) 
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with excitation and emission wavelengths of 360nm and 460nm, respectively. Proteasome 
activity was then determined by taking the difference between samples incubated with and 
without the proteasome inhibitor, and values were normalized to protein content and expressed 
as fluorescence intensity using arbitrary units per milligram of protein. 
Reactive oxygen species (ROS) generation 
Whole muscle reactive oxygen species production was examined using 
dichlorofluorescein-diacetate (DCFH-DA) (Life Technologies, product #: C6827). Intracellular 
esterases hydrolyze DCFH-DA which leads to the formation of non-fluorescent DCFH. DCFH 
can be oxidized by various reactive oxygen species to generate DCF, a highly fluorescent 
molecule. Homogenization of gastrocnemius muscle samples was performed in ice-cold lysis 
buffer (250mM sucrose, 20 mM HEPES, 10 mM KCl, 1 mM EDTA, 1mM EGTA, 1mM DTT; 
pH 7.4) containing protease inhibitors (Complete Cocktail; Roche Diagnostics) in a handheld 
glass homogenizer. After this, the gastrocnemius samples were loaded in duplicate with 5 μM 
DCFH-DA and were subsequently incubated at 37°C in the dark for 1 hour in black 96-well 
plates. A Synergy H1 multi-mode microplate reader (Biotek) with excitation and emission 
wavelengths of 490 nm and 525 nm, respectively, was then used to quantify fluorescence. The 
intensity of the measured fluorescence was normalized to total protein content and presented as 
arbitrary units per milligram of protein. 
Immunofluorescence 
Tibialis anterior muscle samples embedded in OCT compound were cut using a cryostat 
(Thermo Scientific) maintained at -20°C into 10µm cross-sections and were then stored at -80°C. 
Prior to staining, slides were air dried for 10 minutes (Note: this was done at room temperature 
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as were all of the following steps). After this, slides were blocked with 10% goat serum in 1x 
PBS for 1 hour. Primary antibodies against myosin heavy chain (MHC) I (BA-F8; 1:25), 
MHCIIa (SC-71; 1:500), MHCIIb (BF-F3; 1:50), and dystrophin (MANDYS1[3B7]; 1:100) 
(Developmental Studies Hybridoma Bank) were then applied overnight in order to identify 
myosin heavy chain and dystrophin expression. Next, slides were washed 3 times for 5 minutes 
in 1x PBS, and anti-mouse isotype-specific secondary antibodies (Life Technologies) were 
applied for 2 hours. Slides were once again washed 3 times for 5 minutes in 1x PBS, and a #1 
coverslip was mounted on each slide with Prolong Gold antifade reagent. Imaging was 
performed the following day using an Axio Observer Z1 fluorescent microscope equipped with 
an AxioCam HRm camera and associated AxioVision software (Carl Zeiss). Quantitative data 
for fiber type composition was obtained by counting all fibers within a muscle section, and fiber 
type-specific CSA was determined by outlining fibers from 5 separate regions of each cross 
section (30 fibers per muscle fiber type). Whole muscle CSA was determined by outlining the 
entire muscle cross-section. 
Note: Primary and secondary antibody cocktails were prepared in blocking solution (i.e. 
10% goat serum in 1x phosphate-buffered saline [PBS]). The anti-mouse isotype-specific 
secondary antibody used for MHCI was Alexa Fluor 350 IgG2b (blue; 1:500), for MHCIIa was 
Alexa Fluor 488 IgG1 (green; 1:500), for MHCIIb was Alexa Fluor 555 IgM (red; 1:500), and 
for dystrophin was Alexa Fluor 555 IgG2a (red; 1:500).   
Hematoxylin & Eosin (H & E) staining 
 Tibialis anterior muscle cross-sections mounted on microscope slides were first stained 
with hematoxylin for 30 seconds, after which excess hematoxylin was quickly removed. The 
slides were then dipped in distilled water 5 times. After repeating the previous step two more 
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times, cross-sections were stained with eosin for 90 seconds, after which excess eosin was 
quickly removed. Slides were then dipped in 70% ethanol 5 times, 95% ethanol 5 times, and 
100% ethanol 5 times, with excess ethanol being quickly removed between each percentage of 
alcohol. The previous step was repeated one more time. Finally, slides were dipped 5 times in 
xylene, the excess was removed, and permount was applied to mount a #1 coverslip. 
 Muscle damage was quantified on day 3, 7, and 14 by circling the area of the TA cross-
sections occupied by fibers that had visible morphological damage or centralized nuclei. This 
damaged area was then converted into a percentage of the total muscle cross-sectional area. 
Statistical analyses 
Statistical analysis of day 0 protein expression and weight data was performed using 
Student’s t-tests. Analysis of ATG7 protein content in undamaged quadriceps on day 14 was also 
performed using Student’s t-tests. 
Protein expression, enzyme activity, and ROS generation data obtained across the 14 day 
study period was analyzed using a 2-way analysis of variance (ANOVA) and Bonferroni post 
hoc testing, where genotype (2 levels) and time (4 levels) represented the independent variables 
in the ANOVA. Data regarding the proportion of muscle damage was analyzed on day 3, 7, and 
14 by 2-way ANOVA and Bonferroni post hoc tests, where genotype (2 levels) and time (3 
levels) represented the independent variables in the ANOVA. Fiber type distribution, total fiber 
number, fiber type-specific cross-sectional area, and whole muscle cross-sectional area data was 
analyzed on day 0 and 14 using a 2-way ANOVA, where genotype (2 levels) and time (2 levels) 
represented the independent variables. Bonferroni post hoc tests were also conducted if any main 
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effects were discovered. For all tests, p<0.05 was considered statistically significant, while 
0.10≥p≥0.05 was considered a trend towards significance. 
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Results 
Atg7 knockdown on day 0 and the resultant effect on key autophagic markers, body weight, and 
muscle weights 
Immunoblot analyses of gastrocnemius homogenates from day 0 mice revealed a 
reduction of ~61% (p<0.05) in ATG7 protein content in F/F
Cre
 compared to F/F mice (Figure 
5A). While no significant changes in p62 (Figure 5B) or LC3B-I (Figure 5C) expression were 
observed, a trend (p=0.10) towards decreased LC3B-II (Figure 5D) and a significant decrease 
(p<0.05) in the LC3B-II:I ratio (Figure 5E) was seen in the F/F
Cre
 animals. 
A trend (p=0.10) towards significantly lower body weight was discovered in the F/F
Cre
 
group relative to the F/F group on day 0 (Figure 6A). Additionally, a significant reduction 
(p<0.05) in absolute muscle weight was observed in the TA (Figure 6B), gastrocnemius (Figure 
6C), and plantaris (Figure 6D) of the F/F
Cre
 mice compared to the F/F mice. Conversely, absolute 
soleus muscle weight (Figure 6E) was found to be similar between groups. 
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Figure 5: Examination of Atg7 knockdown on day 0 and the resultant effect on key autophagic proteins. 
Quantitative analysis of ATG7 (A), p62 (B), LC3B-I (C), LC3B-II (D), and the LC3B-II:I ratio (E) in the 
gastrocnemius (n=8 per group), along with representative immunoblots of each protein. § significant difference 
between indicated bars as determined by Student’s t-test. 
 
 
Figure 6: Body weight and absolute muscle weights on day 0. Quantification of body weight (A), absolute TA (B), 
gastrocnemius (C), soleus (D), and plantaris (E) muscle weights (n=8 per group). § significant difference between 
indicated bars as determined by Student’s t-test. 
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Body and normalized muscle weights after cardiotoxin injection 
 A main effect of genotype (p<0.05) was found for body weight (BW), with the F/F
Cre
 
mice showing a lower average BW over the study period compared to the F/F mice (Figure 7A). 
A main effect of genotype (p<0.05) was also seen when assessing tibialis anterior weight 
normalized to body weight, with the F/F
Cre
 animals showing higher average TA weight/BW over 
the study period (Figure 7B).  Additionally, a main effect of time (p<0.05) was found with post 
hoc tests revealing increased TA weight/BW on day 3 compared to all other days (Figure 7B). 
Finally, a main effect of time (p<0.05) was found for gastrocnemius weight normalized to body 
weight, with post hoc tests showing increased gastrocnemius weight/BW on day 3 compared to 
all other days, and on day 0 relative to day 7 and 14 (Figure 7C).  
 
Figure 7: Body weight and normalized muscle weights after cardiotoxin injection. Quantification of body weight 
(A), tibialis anterior weight normalized to body weight (B), and gastrocnemius weight normalized to body weight 
(C) over the 14 day study period (n=8 per group). Note: day 0 values presented in this figure for body weight are the 
same as those presented in Figure 6. Ψ significant difference compared to F/F (main effect). * significant difference 
compared to day 0 (main effect). θ significant difference compared to day 7 (main effect). † significant difference 
compared to day 14 (main effect). 
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Autophagic protein expression and cathepsin activity in gastrocnemius after cardiotoxin 
exposure 
A significant interaction effect (p<0.05) was observed for ATG7 expression across the 
study period (Figure 8A). Post hoc tests revealed no significant differences between groups at 
any of the studied time points. Within genotypes, both groups showed lower ATG7 expression 
on day 0 compared to all other days. Additionally, the F/F group showed similar ATG7 content 
on days 3, 7, and 14. Alternatively, while the F/F
Cre
 animals showed similar ATG7 protein levels 
on day 3 compared to day 7, and on day 7 compared to 14, a significant increase in ATG7 
content on day 3 relative to day 14 was observed. A significant main effect of time (p<0.05) was 
observed for p62, with higher levels of p62 expression on both day 0 and day 14 compared to 
day 3 and 7, and day 7 expression being greater than that on day 3 (Figure 8B). A trend (p=0.08) 
towards a genotype effect of higher p62 expression in the F/F
Cre
 animals was also observed 
(statistical trend not noted on graph). LC3B-I protein content also showed a main effect of time 
(p<0.05), with increased levels on day 7 compared to all other time points (Figure 8C). A main 
effect of time (p<0.05) was seen for LC3B-II as well, with post hoc tests showing increased 
content on all days compared to day 0, and on day 7 and 14 relative to day 3 (Figure 8D). 
Finally, a main effect of time (p<0.05) was found for the LC3B-II:I ratio, with day 14 showing a 
higher ratio than all other days (Figure 8E).  
A significant main effect of time (p<0.05) was observed for Beclin-1, with increased 
expression being seen on day 7 compared to all other days, while day 3 and 14 showed increased 
expression compared to day 0 (Figure 8F). A trend (p=0.08) towards higher Beclin-1 content on 
day 3 compared to day 14 was also observed (statistical trend not noted on graph). Analysis of 
ATG4B content also showed a main effect of time (p<0.05), with post hoc tests revealing 
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increased expression at all time points compared to day 0, and increased expression on day 3 and 
7 relative to day 14 (Figure 8G).  
Finally, a main effect of time (p<0.05) was seen for cathepsin activity, with post hoc tests 
showing higher activity on day 3, 7, and 14 compared to day 0, on day 3 compared to day 7 and 
14, and on day 7 compared to day 14 (Figure 12F). 
  
31 
 
 
Figure 8: Autophagic protein expression over the course of the 14 day study period. Quantitative analysis of ATG7 
(A), p62 (B), LC3B-I (C), LC3B-II (D), LC3B-II:I ratio (E), Beclin-1 (F), and ATG4B (G) in the gastrocnemius 
(n=8 per group), along with representative immunoblots of each protein. Note: day 0 values presented in this figure 
for ATG7, p62, LC3B-I, LC3B-II, LC3B-II:I ratio are the same as those presented in Figure 5. $ significant 
difference within genotype compared to day 3, 7, and 14 (interaction effect). Ω significant difference between 
indicated bars (interaction effect). * significant difference compared to day 0 (main effect). # significant difference 
compared to day 3 (main effect). θ significant difference compared to day 7 (main effect). † significant difference 
compared to day 14 (main effect).  
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ATG7 protein content on day 14 in undamaged quadriceps muscle 
Due to the increase in ATG7 protein beyond day 0 in the cardiotoxin-damaged 
gastrocnemius muscle of the F/F
Cre
 mice, we decided to examine whether the return of ATG7 
was an effect of time or whether it was an effect of the muscle being damaged as a result of 
cardiotoxin exposure. To validate our knockdown model and prove that the recovery of ATG7 
expression was not simply an effect of time (i.e. to prove that our knockdown lasted longer than 
the study period), we examined the expression of ATG7 between groups in undamaged 
quadriceps muscle on day 14. Significantly lower (p<0.05) ATG7 protein content was observed 
between groups, with a reduction of ~87% seen in the F/F
Cre
 compared to the F/F animals 
(Figure 9). This result proved that the return of ATG7 protein in the F/F
Cre
 mice was not simply 
an effect of time. 
 
Figure 9: Quantitative analysis of ATG7 protein content on day 14 in undamaged quadriceps muscle. A 
representative immunoblot is also provided (n=5 per group). Means for each group are presented relative to the F/F 
group. § significant difference between the indicated bars as determined by Student’s  t-test. 
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Ubiquitin-proteasome related protein expression and proteasome activity in gastrocnemius post-
cardiotoxin injection 
 A significant main effect of time (p<0.05) was seen for both MAFbx (Figure 10A) and 
MuRF1 (Figure 10B) protein expression in the gastrocnemius, with post hoc tests showing lower 
levels on day 3, 7, and 14 compared to day 0, and  increased levels on day 14 relative to day 3 
and  7. Post hoc analysis of MuRF1 also showed a trend (p=0.10) towards increased expression 
on day 7 compared to day 3.  
A main effect of time (p<0.05) was also seen for proteasome activity in the 
gastrocnemius, with higher activity being observed on both day 7 and day 14 compared to day 0 
and day 3 (Figure 12F).  
 
Figure 10: Ubiquitin-proteasome related protein expression over the 14 day study period. Quantitative analysis of 
MAFbx (A) and MuRF1 (B) in the gastrocnemius (n=8 per group), along with representative immunoblots of each 
protein. # significant difference compared to day, 3, 7, and 14 (main effect). θ significant difference compared to 
day 3 and 7 (main effect).  
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Expression of apoptotic proteins in gastrocnemius in response to cardiotoxin exposure 
 A significant main effect of time (p<0.05) was discovered for Bax, with higher 
expression observed on day 3 and 7 compared to day 0 and 14 (Figure 11A). Bcl-2 also showed a 
main effect of time (p<0.05), with post hoc tests revealing increased Bcl-2 content on day 3, 7, 
and 14 compared to day 0, along with increased expression on day 3 and 7 relative to day 14  
(Figure 11B). Interestingly, no effects were observed for the Bax:Bcl-2 ratio (Figure 11C). A 
significant main effect of time (p<0.05) was seen for Bid, with higher expression seen on day 3 
compared to day 0 and 14, and on day 7 compared to day 0 (Figure 11D). A significant time 
effect (p<0.05) was also observed for  tBid, as post hoc tests showed higher levels on day 0 and 
14 relative to day 3 and 7 (Figure 11E). These results contributed to a main effect of time 
(p<0.05) for the tBid:Bid ratio, with post hoc tests revealing an increased ratio on day 0 
compared to all other days, and on day 14 compared to day 3 and 7 (Figure 11F). Finally, XIAP 
expression also showed a significant main effect of time (p<0.05), with higher expression 
observed on day 3, 7 and 14 relative to day 0, and on day 3 compared to day 14 (Figure 11G). A 
strong trend (p=0.05) towards higher XIAP levels on day 7 relative to day 14 was also 
discovered (statistical trend not noted on graph). 
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Figure 11: Apoptotic protein expression over the 14 day study period. Quantitative analysis of Bax (A), Bcl-2 (B), 
Bax:Bcl-2 ratio (C), Bid (D), tBid (E), tBid:Bid ratio (F), and XIAP (G) in the gastrocnemius (n=8 per group), along 
with representative immunoblots of each protein. * significant difference compared to day 0 (main effect). # 
significant difference compared to day 3 (main effect). θ significant difference compared to day 7 (main effect). † 
significant difference compared to day 14 (main effect).  
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Caspase and calpain activity in gastrocnemius after cardiotoxin injection 
 A significant main effect of time (p<0.05) was observed for caspase-3, with higher 
activity seen on day 7 compared to all other days, and on day 3 and 14 relative to day 0 (Figure 
12A). Additionally, a main effect of time (p<0.05) was observed for caspase-8, which showed 
higher activity on day 7 relative to all other time points, and on day 14 compared to day 0 and 3 
(Figure 12B). Caspase-9 also showed a main effect of time (p<0.05), with post hoc tests 
revealing higher activity again on day 7 compared to all other days, and on day 3 and 14 relative 
to day 0 (Figure 12C).  
Calpain activity showed a significant effect of time (p<0.05) and also a trend (p=0.10) 
towards an interaction effect (Figure 12D). In reference to the time effect, calpain activity was 
elevated (p<0.05) on day 7 and day 14 relative to both day 0 and 3. 
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Figure 12: Enzyme activity over the course of the 14 day study period. Quantitative analysis of caspase-3 (A), 
caspase-8 (B), caspase-9 (C), calpain (D), cathepsin (E), and proteasome (F) activity in the gastrocnemius (n=8 per 
group). Statistical trend towards interaction effect is listed above graph if present. * significant difference compared 
to day 0 (main effect). # significant difference compared to day 3 (main effect). θ significant difference compared to 
day 7 (main effect). † significant difference compared to day 14 (main effect). 
 
Expression of stress-related, antioxidant, and mitochondrial proteins, and ROS generation in 
gastrocnemius after cardiotoxin injection 
A significant main effect of time (p<0.05) was seen for both Hsp70 (Figure 13A) and 
catalase (Figure 13B), with post hoc tests showing increased expression on day 3 and 7 relative 
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to day 0 and 14, and on day 14 relative to day 0. MnSOD levels also showed a main effect of 
time (p<0.05), with higher expression on day 0 compared to all time points, on day 14 compared 
to day 3 and 7, and on day 7 compared to day 3  (Figure 13C).  Additionally, CuZnSOD showed 
a main effect of time (p<0.05), with day 0, 7, and 14 all showing higher (p<0.05) expression than 
day 3 (Figure 13D). A strong trend (p=0.05) towards increased CuZnSOD expression on day 0 
relative to day 7 was also observed (statistical trend not noted on graph). Finally, a main effect of 
time (p<0.05) was observed for cytochrome c content, with day 0 showing significantly higher 
levels than day 3 (Figure 13E) and a trend (p=0.06) towards higher levels than day 7 (statistical 
trend not noted on graph). Elevated (p<0.05) cytochrome c expression was also seen on day 14 
compared to day 3 and 7 (Figure 13E). 
In regard to ROS production, a main effect of time (p<0.05) was discovered, with post 
hoc tests revealing increased ROS on day 3 and 7 compared to day 0, and on day 3 compared to 
day 14 (Figure 13F). A trend (p=0.09) towards higher ROS production on day 7 relative to day 
14 was also observed (Figure 13F). 
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Figure 13: Expression of stress-related, antioxidant, and mitochondrial proteins, and ROS generation over the study 
period. Quantitative analysis of Hsp70 (A), catalase (B), MnSOD (C), CuZnSOD (D), and cytochrome C (E), as 
well as ROS generation (F) in the gastrocnemius (n=8 per group). Representative immunoblots of each protein are 
also presented. * significant difference compared to day 0 (main effect). # significant difference compared to day 3 
(main effect). θ significant difference compared to day 7 (main effect). † significant difference compared to day 14 
(main effect). 
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Muscle damage 
 No significant effects were observed when analyzing the proportion of damaged area on 
TA muscle cross-sections using a 2-way ANOVA, although there was a trend (p=0.07) towards a 
significant interaction effect (Figure 14A). 
 
Figure 14: Muscle damage in TA after cardiotoxin exposure. Quantitative analysis of the damaged area in the 
muscle cross-sections as a percentage of the total area on day 3, 7, and 14 (A) (n=7 per group). No quantifiable 
damage was observed on day 0 in either group, therefore, a measure of damaged area was not determined (n.d.) at 
this time point. Also displayed are representative tibialis anterior cross-sections stained with H & E showing the 
progression of damage in both genotypes on day 0, 3, 7, and 14 (B). Interaction effect is listed above graph if 
present. 
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Tibialis anterior fiber type distribution, fiber type-specific CSA, and whole muscle CSA 
 A main effect of time (p<0.05) was observed for the percentage of type IIA fibers, with a 
higher percentage being seen on day 0 compared to day 14 (Figure 15A). In regards to type 
IIA/X fibers, a main effect of time (p<0.05) and a main effect of genotype (p<0.05) were 
discovered, with the percentage of type IIA/X fibers being higher on day 14 relative to day 0, 
and in the F/F
Cre
 animals compared to the F/F animals (Figure 15B). No effects were observed in 
the distribution of type IIX fibers (Figure 15C). Conversely, a main effect of time (p<0.05) was 
seen when examining the percentage of type IIX/B fibers, with a higher percentage on day 14 
relative to day 0 (Figure 15D). Finally, a main effect of time (p<0.05) was observed for the 
percentage of type IIB fibers, with a higher percentage being seen on day 0 relative to day 14 
(Figure 15E). A trend (p=0.07) towards a main effect of genotype was also observed for the 
percentage of type IIB fibers (Figure 15E). Of note, a significant main effect of time (p<0.05) 
was observed when examining the total number of fibers in the muscle cross-sections, with a 
higher number of fibers being seen on day 14 compared to day 0 (Figure 15F).  
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Figure 15: Muscle fiber type distribution and total fiber number in tibialis anterior. Quantification of the percentage 
of type IIA (A), IIA/X (B), IIX (C), IIX/B (D), and IIB (E) fibers in the muscle cross-sections. Quantification of 
total fiber number (F) is also presented (n=6 per group). * significant difference compared to day 14 (main effect). # 
significant difference compared to day 0 (main effect). Ψ significant difference compared to F/F (main effect). 
 
 Analysis of fiber type cross-sectional area in the TA revealed a significant interaction 
effect (p<0.05) for type IIA (Figure 16A), IIX (Figure 16C), and IIX/B fiber CSA (Figure 16D). 
Post hoc analysis revealed increased type IIA and IIX fiber CSA in the F/F
Cre
 mice on day 14 
compared to the F/F
Cre
 mice on day 0, and compared to the F/F mice on day 0 and 14 (Figure 
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16A and Figure 16C). Additionally, post hoc tests displayed increased type IIX/B fiber CSA in 
the F/F
Cre
 animals on day 14 relative to the  F/F
Cre
 animals on day 0, and relative to the F/F 
animals on day 14 (Figure 16D). A significant interaction effect (p<0.05) was also seen for type 
IIB fiber CSA (Figure 16E), although post hoc tests did not reveal any significant differences. 
For type IIA/X fibers (Figure 16B), a trend (p=0.06) towards a significant interaction effect was 
discovered, as was a significant main effect of genotype (p<0.05), with the F/F
Cre
 group 
displaying higher average type IIA/X fiber CSA compared to the F/F group. A trend (p=0.05) 
towards a significant main effect of time was also observed for type IIA/X fiber CSA. A 
significant interaction effect (p<0.05) was observed when analyzing whole muscle cross-
sectional area of the TA (Figure 16F). Post hoc analysis displayed no CSA differences between 
day 0 and 14 in the F/F mice, while a trend (p=0.07) towards a significant increase in CSA was 
seen over this time in the F/F
Cre
 mice.  
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Figure 16: Fiber type cross-sectional area and whole muscle cross-sectional area in TA. Quantification of type IIA 
(A), IIA/X (B), IIX (C), IIX/B (D), and IIB (E) fiber cross-sectional area, as well as whole muscle cross-sectional 
area (F) (n=6 per group). Statistical trend towards interaction effect is listed above graph if present. * significant 
difference compared to all other bars (interaction effect). # significant difference compared to F/F
Cre
 day 0 and F/F 
day 14 (interaction effect). Ψ significant difference compared to F/F (main effect).   
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Discussion 
The goals of this Master’s thesis were to investigate the role of autophagy in modulating 
apoptotic signaling in skeletal muscle following cardiotoxin-induced muscle injury, and to 
examine the role that autophagy plays in skeletal muscle recovery after cardiotoxin-induced 
muscle damage. It was believed that using a skeletal muscle-specific Atg7 knockdown (i.e. 
autophagy deficient) mouse model would be an ideal way to answer these questions. 
Furthermore, it was believed that using a tamoxifen inducible knockdown model rather than a 
constitutive knockdown model would provide more applicable conclusions as the inducible 
knockdown mice maintain their autophagic capabilities during development and up until the 
point of tamoxifen injection, whereas gene recombination and autophagy inhibition occur 
throughout the life cycle in the constitutive knockdown mice
71
. Therefore, the inducible 
knockdown model was thought to be more appropriate to study because these mice circumvent 
any potential adaptations that may have occurred during development in the constitutive 
knockdown mice to compensate for the lack of autophagy. Tamoxifen-inducible, skeletal 
muscle-specific Atg7 knockdown mice have been studied previously in the literature to examine 
the role of autophagy under basal conditions, during exercise, and during aging (this will be 
discussed in more detail below)
72-74
. However, these animals have not been used to investigate 
the role of autophagy in conditions of acute, extensive muscle trauma like those imposed in this 
Master’s thesis.  
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In 2009, Masiero and colleagues examined constitutive skeletal muscle-specific Atg7 
knockout (KO) mice as well as tamoxifen-inducible, skeletal muscle-specific Atg7 KO mice 
similar to the one used in the current Master’s thesis72. Under basal conditions, ATG7 protein 
expression was nearly undetectable in 2 month old constitutive Atg7 KO mice, and the small 
amounts discovered by immunoblots were attributed to the presence of other cells (e.g. 
fibroblasts, blood cells, etc.) within the muscle
72
. This extensive Atg7 KO led to an accumulation 
of p62 and to an inhibition of LC3-I lipidation in both oxidative and glycolytic muscles. The 
inhibition of autophagy in these constitutive Atg7 KO animals caused degenerative changes such 
as increased vacuolated and centrally nucleated fibers, as well as atrophy of oxidative and 
glycolytic fibers (in both males and females)
72
. Additionally, these authors found increased 
MAFbx and MuRF1 expression, increased proteasome activity, and increased apoptotic nuclei in 
these mice
72
. Electron microscopy also revealed a misalignment of z-discs, sarcoplasmic 
reticulum distension, and an accumulation of swollen, abnormal mitochondria, and in the 
constitutive Atg7 KO mice
72
. Moreover, the observed mitochondrial dysfunction lead to 
increased oxidative stress as seen by elevated levels of protein carbonylation
72
. Finally, a 
decrease in both absolute and specific muscle force was discovered in the constitutive Atg7 KO 
animals
72
. While the analysis was not quite as extensive, these authors found a similar expression 
profile for ATG7, p62, and LC3, similar morphological alterations and atrophy, and similar 
decreases in muscle force in the tamoxifen-inducible, skeletal muscle-specific Atg7 KO mice 
compared to the constitutive KO animals
72
. Interestingly, more centrally nucleated fibers were 
seen in the inducible KO mice relative to the constitutive KO mice
72
. In the current Master’s 
thesis, a significant decrease (~61%) in ATG7 expression was observed in the gastrocnemius of 
the F/F
Cre
 animals on day 0, however this decrease was not as drastic as that seen by Masiero and 
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colleagues. This less extensive Atg7 knockdown likely accounts for the lack of p62 accumulation 
and for the relatively decreased inhibition of LC3 lipidation in the F/F
Cre
 animals on day 0 
relative to the mice examined in the Masiero study. Furthermore, these differences in ATG7, 
p62, and LC3 expression suggest a reduced inhibition of autophagy in the current thesis 
compared to that achieved by Masiero et al., which could explain the different results obtained 
between the two studies. It is possible that a lower degree of autophagy inhibition in the current 
thesis was accompanied by a reduced accumulation of cellular debris (as seen by an absence of 
p62 accumulation) and damaged mitochondria, resulting in similar levels of ROS production and 
fiber regeneration (i.e. as seen by a lack of an increase in centrally nucleated fibers) between the 
F/F and F/F
Cre
 animals on day 0. Decreased autophagy inhibition may also explain why fiber 
atrophy was limited to glycolytic fibers in the current thesis. Previous research has suggested a 
decreased reliance on autophagy in oxidative fibers, as evidenced by much lower levels of 
autophagic flux in oxidative muscle (soleus) compared to glycolytic muscle (extensor digitorum 
longus) in colchicine-treated, wild-type mice under basal conditions (unpublished work, 
Quadrilatero lab). The idea of increased reliance on autophagy in glycolytic fibers is also 
supported by a study by Mizushima and colleagues, who found a faster and greater activation of 
autophagy in glycolytic muscle (EDL) compared to oxidative muscle (soleus) in response to 
fasting by examining levels of LC3 protein tagged with green fluorescent protein (GFP)
75
. 
Another study by Ogata and colleagues also demonstrated greater autophagic activation in 
glycolytic muscle (plantaris) compared to oxidative muscle (soleus) in response to fasting as 
seen by faster and greater increases in LC3B-II and p62 in the plantaris
76
. Consequently, in 
contrast to the study by Masiero and colleagues, it is possible that the level of autophagy 
inhibition achieved in this Master’s thesis was not great enough to cause atrophy in the more 
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oxidative fiber types. Finally, the decreased inhibition of autophagy in the current study probably 
explains the lack of a compensatory increase in UPS system activity like that seen by Masiero 
and colleagues. Clearly, a difference between the knockout models used by Masiero et al. and the 
current thesis exists, which led to dramatic variations in the results obtained under basal 
conditions.           
Other studies examining the effects of autophagy inhibition under basal conditions in 
constitutive, skeletal muscle-specific Atg7 KO mice have also found reductions in ATG7 protein 
in conjunction with an accumulation of p62 and decreased LC3 lipidation
77, 78
. In agreement with 
the current study, Kim et al. discovered lower body and gastrocnemius weight as a result of 
muscle-specific autophagy inhibition
77
. Interestingly, while predominantly glycolytic muscles 
(i.e. TA, gastrocnemius, plantaris) underwent atrophy in the F/F
Cre
 mice on day 0, atrophy of the 
more oxidative soleus muscle was not observed under basal conditions. This could suggest that 
oxidative muscles are less susceptible to autophagy inhibition-induced muscle atrophy, possibly 
due to the decreased reliance on autophagy in oxidative fibers as discussed above. Also similar to 
the current thesis, Wu and colleagues found no apparent morphological abnormalities in the Atg7 
KO mice compared to the control mice on H & E stained muscle cross-sections
78
. However, Wu 
et al. did discover an accumulation of abnormal, swollen mitochondria along with decreases in 
mitochondrial function in their Atg7 KO animals, and increased ROS production in murine 
embryonic fibroblasts (MEFs) isolated from Atg7 KO embryos
78
. While the current thesis did 
not examine mitochondrial morphology or function, no increases in ROS production were 
discovered in the F/F
Cre
 mice on day 0; however, it should be noted that the assay used in this 
study was a general measure of ROS rather than a mitochondrial-specific ROS measurement. It 
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is possible that constitutive muscle-specific Atg7 KO has a greater effect on the mitochondria, 
resulting in higher levels of ROS generation.  
As mentioned above, tamoxifen-inducible, skeletal muscle-specific Atg7 knockdown 
mice similar to those used in the current Master’s thesis have been used to investigate the role of 
autophagy during exercise
73
. This study by Lo Verso et al. (which used the same mice as the 
Masiero et al. study) found that under basal conditions, the Atg7 knockout animals displayed 
marked increases in p62 and LC3-I, and increased levels of mitochondrial dysfunction and ROS 
generation
73
. Again, no differences in basal ROS production were observed in the current thesis, 
perhaps due to a lower degree of autophagy inhibition. These authors also found that when 
subjected to concentric (uphill) treadmill exercise to exhaustion, neither male nor female Atg7 
knockout mice showed differences in running capacity or morphological signs of damage 
compared to controls
73
. In contrast, when subjected to a single bout of eccentric (downhill) 
treadmill running, decreased running capacity was observed in the Atg7 knockout mice, but this 
effect was limited to the female animals
73
.  Furthermore, after 3 days of eccentric exercise, 
female Atg7 knockout mice again displayed decreased running capacity relative to controls
73
. 
Notably, this decreased performance was not caused by any exercise-related structural 
alterations, as no signs of inflammation, necrosis, or plasma membrane disruption were seen in 
the muscles of the female Atg7 knockout or control animals
73
. The absence of major 
morphological alterations in these animals after eccentric exercise is noteworthy since this type 
of exercise is commonly thought to promote muscle damage. The sex-specific effect of 
autophagy inhibition on exercise performance is also notable and suggests that future research 
investigating autophagic mechanisms should examine both male and female subjects. Despite 
different in running capacity, both male and female Atg7 KO mice displayed a decrease in 
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mitochondrial function over time as a result of eccentric exercise, although the effect was greater 
in females
73
. This mitochondrial dysfunction was associated with increased ROS production; 
however, this did not seem to be the cause of decreased running capacity in the female Atg7 
knockout animals as treatment with an antioxidant did not improve their running performance
73
 . 
Overall, the authors concluded that autophagy plays a major role in maintaining mitochondrial 
function during exercise
73
. As previously discussed, the current thesis did not conduct any direct 
measures of mitochondrial function, but it would be interesting to see how the mitochondria 
responded to cardiotoxin-induced damage in mice that remained autophagy deficient throughout 
the process of muscle recovery. Since autophagy normally plays a role in cell quality control and 
removing damaged mitochondria, it is hypothesized that an inhibition of autophagy during 
cardiotoxin exposure would lead to an accumulation of dysfunctional mitochondria, which could 
subsequently lead to delayed muscle regeneration due to deficient energy production in the cell.  
Finally, a study by Carnio and colleagues investigated the role of autophagy at the 
neuromuscular junction (NMJ) and during aging using the same inducible Atg7 KO mice as the 
Masiero et al study
72, 74
. These authors induced a skeletal muscle-specific inhibition of autophagy 
in 22 month old mice, which they sacrificed 3 months later. They found that suppressing 
autophagy led to an accumulation of p62 and LC3-I, as well as increased levels of muscle 
breakdown as evidenced by an approximately 2-fold increase in centrally nucleated fibers and by 
a decrease in fiber cross-sectional area
74
. Another observation in this study was that the Atg7 
knockout mice displayed an increase in neural cell adhesion molecule (NCAM)-positive cells 
compared to aged matched controls, suggesting a significant loss of muscle innervation since 
NCAM becomes highly expressed along the entire length of adult muscle fibers if denervation 
occurs
74
. It should be noted that while these authors showed an accumulation of p62 and LC3-I 
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in the 25 month old Atg7 KO mice (i.e. 3 months after autophagy inhibition), they did not 
measure ATG7 expression (or at least did not present a measurement of ATG7) in these animals. 
It is possible that some ATG7 restoration could have occurred in these animals since some level 
of muscle regeneration and satellite cell incorporation may have taken place over the 3 month 
intervention period. On the other hand, perhaps the amount of muscle regeneration taking place 
in these mice was so low that there was no significant satellite cell activation, and in turn, there 
was no significant ATG7 restoration. Whatever the case, future studies using inducible, skeletal 
muscle-specific Atg7 knockdown mice should examine ATG7 protein content after the 
intervention period to confirm that the knock down of Atg7 is maintained. An additional 
interesting finding of this study was that autophagy was shown to decrease with age in both mice 
and humans
74
. The authors questioned whether this reduction in autophagy may play a role in the 
muscle degeneration seen with aging, so they overexpressed ATG7 in aged (26 month old) F/F 
mice to see if restoring autophagic flux helped to reduce muscle breakdown. Indeed, it was 
discovered that the mice overexpressing ATG7 displayed decreased fragmentation of the NMJ, a 
reduced number of NCAM-positive fibers, and increased muscle mass compared to age-matched 
controls
74
. These results suggest that autophagy inhibition during aging is involved with muscle 
atrophy, and that the enhancement of autophagic signaling in skeletal muscle during aging could 
play a role in preventing sarcopenia. Results from the current thesis also showed that restoring 
autophagic function could promote enhancements in muscle mass, as muscle weights returned to 
control levels in the F/F
Cre
 mice on day 14 (i.e. when ATG7 expression was restored in these 
animals)(Appendix Figure A2) despite weighing less on day 0 (i.e. when ATG7 expression was 
reduced). Interestingly, autophagy inhibition-induced muscle atrophy seemed to be limited to 
glycolytic muscles in the current thesis, as TA, gastrocnemius, and plantaris muscle weights 
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were reduced in the F/F
Cre
 mice compared to the F/F mice on day 0, but soleus weight was not 
different between groups at this time point. This could be due to a greater reliance on autophagy 
in glycolytic muscles as discussed above. 
Despite the promising potential conclusions that could have been derived from studying 
tamoxifen-inducible, skeletal muscle-specific Atg7 KO mice in this thesis, it appears as though 
this was not the best animal model to use in conjunction with an intervention causing widespread 
muscle damage and regeneration (e.g. cardiotoxin injury). While the model proved to cause a 
significant knockdown of the Atg7 gene and a significant corresponding reduction of ATG7 
protein in a skeletal muscle-specific manner on day 0 (i.e. prior to cardiotoxin treatment), this did 
not remain true after intramuscular cardiotoxin injections. As seen above, ATG7 protein 
expression increased dramatically in the F/F
Cre
 animals 3 days after cardiotoxin injection. 
Beyond day 3, similar ATG7 protein expression was observed between groups, showing that 
both groups had a similar genetic composition on day 7 and 14. This was unfortunate as it was 
hoped that the Atg7 knockdown would persist throughout the 14 day study period to allow for 
examination of the apoptotic response to muscle injury and of the skeletal muscle recovery 
process in absence of autophagy in the F/F
Cre
 animals. It was interesting to see that the Atg7 
knockdown did persist in the undamaged quadriceps muscle on day 14, as this verified the fact 
that the return of ATG7 protein expression was associated with the induction of damage and was 
not simply caused by a problem with the functionality of the model. Additionally, this 
information provided clues as to why the expression of Atg7 was restored in the F/F
Cre
 mice 
post-cardiotoxin injection.  
In the mouse model used for this study, Cre-driven recombination of the Atg7 gene was 
under control of the HSA promoter. The α-skeletal actin protein isoform produced by this gene is 
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highly expressed in skeletal muscle
79
, and in turn, large amounts of the MerCreMer protein 
complex would also be expressed. Conversely, quiescent satellite cells do not express α-skeletal 
actin
80
, and in turn would not express the MerCreMer protein complex. Additionally, it is 
important to note that quiescent satellite cells are located between the sarcolemma and the basal 
lamina of the muscle fibers, and therefore are not part of the muscle fibers themselves
81
. These 
facts can be used to see that the tamoxifen injections caused Atg7 knockdown in the myonuclei 
but not in the quiescent satellite cell nuclei. Due to the high expression levels of the MerCreMer 
protein complex in the muscle (i.e. because of high HSA promoter activity), tamoxifen injection 
would cause this complex to translocate from the cytoplasm into the myonuclei and cause 
recombination of the Atg7 gene. Alternatively, the quiescent satellite cells did not express the 
MerCreMer complex in their cytoplasm, and in turn, no recombination of the Atg7 gene occurred 
in the satellite cell nuclei despite the injection of tamoxifen. Moreover, since the quiescent 
satellite cells are separate from the muscle fibers, the MerCreMer complexes present in the 
muscle would not be able to gain access to the satellite cell nuclei even in the presence of 
tamoxifen. Consequently, as the muscle recruited satellite cells in order to regenerate after the 
cardiotoxin-induced damage, it regained nuclei that possessed the Atg7 gene. This led to a 
subsequent increase in ATG7 protein and an elimination of the Atg7 knockdown. Importantly, 
the knockdown of the Atg7 gene and the reduction of ATG7 protein were not restored after 
satellite cell fusion because tamoxifen was no longer in the animals’ system since injections of 
tamoxifen were no longer being administered. Accordingly, even though more of the MerCreMer 
protein complex was being produced through activation of the HSA promoter during muscle cell 
differentiation and remodeling, it was not able to translocate to the nucleus and cause Atg7 
recombination. 
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The literature regarding satellite cells has found that satellite cell activation, proliferation, 
and fusion begins 1-2 days after muscle injury
82
. Satellite cell activation is thought to be 
promoted by a variety of signals. These signals include the production of sphingosine-1-
phosphate inside the plasma membrane of the satellite cell
83
, and a nitric oxide-dependent release 
of hepatocyte growth factor (HGF), which binds to receptors on the satellite cells
84
. While HGF 
appears to activate and promote proliferation of satellite cells, it also seems to inhibit 
differentiation of these cells
85
. The transition from satellite cell proliferation to differentiation is 
thought to depend on the balance between Notch and Wnt signaling, as Notch signaling is 
elevated early on after muscle injury as the satellite cells proliferate, while Wnt signaling 
increases significantly as early as 2 days after muscle injury and continues to increase over time 
as the satellite cells differentiate
86
. On a related note, a study by Sesodia and colleagues showed 
that some enzymes can regain normal activity levels as early as 3 days after muscle damage 
induced by notexin (i.e. a myotoxin derived from tiger snake venom)
87
. These findings help to 
further explain how ATG7 protein levels were restored as early as day 3 in the F/F
Cre
 animals in 
the current study. Within the first couple of days after cardiotoxin-damage, satellite cells in the 
injured muscle were activated and proliferated. Then, as early as 2 days after injury, these 
satellite cells differentiated and matured into functional myonuclei. At this point, these new 
myonuclei began to transcribe mRNA which was subsequently translated into protein. Since 
autophagy appears to be upregulated in response to muscle damage (i.e. as evidenced by 
increased ATG7 and Beclin-1 protein content, as well as cathepsin activity in the F/F mice), and 
these new myonuclei contained copies of the Atg7 gene in their DNA, an increase in ATG7 
protein occurred in the F/F
Cre
 animals.  
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Another factor that may have contributed to the increased ATG7 expression in the F/F
Cre
 
mice after cardiotoxin injection is the possibility that gene recombination did not occur in all of 
the myonuclei. As discussed above, previous research in Atg7 KO animals has shown extensive 
ATG7 knockdown and subsequent increases in p62 and LC3-I content
72, 73, 78
. Conversely, ATG7 
expression was only decreased by ~61% in the gastrocnemius of the F/F
Cre
 mice in the current 
thesis, and no significant accumulation of p62 or LC3B-I was observed on day 0. The less 
extensive knockdown of Atg7 and less severe inhibition of autophagy in the F/F
Cre
 mice may 
signify that some myonuclei maintained the ability to generate ATG7 protein even after 
tamoxifen administration. If true, these Atg7
+/+ 
myonuclei could have upregulated ATG7 
production in response to cardiotoxin exposure, contributing to the observed restoration of ATG7 
content. Additionally, the infiltration of various cell types such as macrophages, neutrophils, and 
blood cells into the muscle after cardiotoxin injury could have contributed to the increased ATG7 
expression measured by immunoblotting since these cells would have also been present in the 
muscle homogenates that were analyzed. 
Although definitive conclusions regarding the effects of autophagy inhibition on 
apoptotic signaling and muscle regeneration could not really be drawn due to the restoration of 
ATG7 content in the F/F
Cre
 animals, it was still possible to evaluate the autophagic and apoptotic 
responses to cardiotoxin-induced muscle injury and the relationship between the two pathways. 
Marked increases in ATG7, LC3B-II, Beclin-1, ATG4B, and cathepsin activity along with a 
drastic decrease in p62 content were observed on day 3, suggesting a large upregulation of 
autophagic flux at this time point. This increased autophagic signaling likely occurred in order to 
remove the large amounts of damage produced by cardiotoxin exposure. Furthermore, 
autophagic flux appeared to remain significantly elevated on day 7, as ATG7 and ATG4B 
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content remained increased and the expression of LC3B-I, LC3B-II, and Beclin-1 increased to 
levels greater than those seen on day 3. Notably, p62 expression increased slightly and cathepsin 
activity was slightly reduced on day 7 compared to day 3. These findings seem to indicate that 
autophagic flux peaked on day 3 and began to decrease slightly on day 7, as a rise in p62 content 
suggests a decrease in autophagy (i.e. since p62 is normally degraded by autophagy)
72
 and 
decreased cathepsin activity suggests a reduction in autophagosome breakdown (i.e. since 
cathepsins are lysosomal enzymes that contribute to autophagosome degradation)
88
. On day 14, 
ATG7, ATG4B, LC3B-I, and Beclin-1 content was reduced compared to day 7, as was cathepsin 
activity. Additionally, the expression of p62 returned to the basal levels seen on day 0, 
suggesting a further decrease in autophagic flux relative to day 7. Interestingly, LC3B-II content 
and the LC3B-II:I ratio remained elevated to the same level as seen on day 7. Overall, the results 
obtained in the current study indicate that autophagic flux was stimulated by cardiotoxin-induced 
damage, peaked on day 3, and then continued to decrease over time. Notably, it is possible that 
autophagic flux actually peaked somewhere between day 3 and day 7; however, this could not be 
determined since no time points were analyzed between these two days. It was interesting to see 
that the UPS system seemed to respond in an opposite manner compared to autophagy after 
cardiotoxin-induced damage. Expression of both MAFbx and MuRF1 was significantly reduced 
on day 3 and 7 relative to day 0, but was increased on day 14 compared to day 3 and 7. It was 
also observed that proteasome activity did not increase compared to day 0 until day 7, and this 
activity remained elevated on day 14. This is noteworthy since increases in both autophagy and 
UPS activation have been observed under atrophic conditions
72, 89
. It appears that the 
coordination of these two degradative pathways is different in response to acute muscle damage 
as compared to more chronic atrophy conditions, and that increased activity of one of these 
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proteolytic systems can result in decreased activity of the other system. Indeed, an upregulation 
of autophagy along with decreased activity of the UPS has been seen before and vice versa
72, 90
.  
Interestingly, apoptotic signaling showed a different activation profile compared to 
autophagic signaling. While caspase-3 and caspase-9 activity was slightly increased on day 3 
compared to day 0, the activity of these enzymes, along with caspase-8 and calpains, did not 
peak until day 7. The activity of these enzymes then decreased on day 14 (with the exception of 
calpains), but remained elevated compared to day 0. Notably, while Bax expression increased on 
day 3 and day 7, so too did Bcl-2 expression causing a similar Bax:Bcl-2 ratio between days. 
This increase in anti-apoptotic Bcl-2 along with increases in the anti-apoptotic protein XIAP on 
day 3 and 7 likely represented a cellular response to suppress extreme elevations in apoptotic 
signaling. Increases in Hsp70 and catalase content on day 3 and 7 may have also represented an 
attempt to inhibit elevations in apoptotic signaling and suppress increases in ROS production.  
Overall, these findings regarding autophagic and apoptotic signaling suggest that 
autophagy is activated to a greater degree early on after cardiotoxin injury, while the activation 
of apoptosis occurs slightly later. From these results, it is hypothesized that autophagy is more 
involved in the response to muscle damage and in the “cleanup” of the muscle fibers after acute 
injury, while apoptosis is more involved in the remodeling and regeneration of muscle fibers. 
This is speculated because the inflammatory response to cardiotoxin-induced damage has been 
shown to peak 1-4 days after cardiotoxin injection, while the regeneration of muscle fibers has 
been observed to occur ~5-6 days after cardiotoxin treatment
91
. These results also suggest that 
although autophagy activation is followed by increased apoptotic signaling in response to 
skeletal muscle damage, this level of apoptosis is not necessarily associated with an induction of 
cell death as the muscle fibers actually regenerate rather than die. In fact, the activation of 
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autophagy may represent a cellular response that indirectly suppresses apoptotic signaling and 
prevents higher levels of cell stress and atrophy. Indeed, decreased expression of cytochrome c, 
MnSOD, and CuZnSOD was observed on day 3, the same time that autophagic signaling 
appeared to peak. Reductions in cytochrome c and MnSOD may represent an induction of 
mitophagy (i.e. autophagic breakdown of mitochondria) in order to eliminate dysfunctional 
mitochondria that would otherwise produce high levels of superoxide which could elevate 
apoptotic signaling. Decreased CuZnSOD expression on day 3 supports this idea as this enzyme 
normally helps to degrade superoxide in the cytosol and prevent oxidative stress
92
. Furthermore, 
extreme reductions in tBid expression and the tBid:Bid ratio were observed on day 3 and day 7 
when autophagic signaling was elevated. Activated tBid has been shown to facilitate cytochrome 
c release from the mitochondria and consequently cause an activation of caspases
93
. Therefore, 
large reductions in tBid, potentially as a result of autophagy-mediated degradation (i.e. since 
autophagic activity was greatly increased on day 3 and 7 at the time of tBid degradation), may 
represent another mechanism of apoptosis inhibition by autophagy.  
All in all, while some research has associated concomitant elevations of autophagic and 
apoptotic signaling with toxic effects
94-96
, and consequently it has been proposed that autophagy 
is a cytotoxic process, the current thesis suggests that this may not be the case. Early increases in 
autophagy after cardiotoxin injury were met by only slightly elevated levels of apoptotic 
signaling, and apoptotic activity did not appear to peak until autophagic signaling had begun to 
decrease. These results demonstrate that examining the timing of the increased autophagic and 
apoptotic signaling by analyzing different time points is equally important as investigating the 
absolute elevations in signaling. When this approach was taken in the current Master’s thesis, it 
appeared that autophagy induction may have played a cytoprotective role in skeletal muscle after 
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cardiotoxin exposure by potentially reducing cell stress and indirectly blunting the apoptotic 
response. It would have been very interesting to see if apoptotic signaling was elevated earlier 
and/or to a greater extent in the F/F
Cre
 mice had the knockdown of Atg7 persisted, as this would 
have more definitely elucidated whether autophagic activation was involved in suppressing 
apoptotic signaling. Indeed, a study by McMillan & Quadrilatero showed that an inhibition of 
autophagy by 3-methyladenine (3MA) during myoblast differentiation caused increased transient 
caspase-3 activation, apoptotic nuclei, and DNA fragmentation
97
. An inhibition of autophagy by 
Atg7 shRNA also caused elevated DNA fragmentation in differentiating myoblasts
97
. 
Additionally, this study showed that autophagic signaling increased transiently during myoblast 
differentiation
97
. This suggests that the differentiation of satellite cells in the regenerating muscle 
could have contributed to the early increases in autophagy seen in the current thesis. The 
differentiation of satellite cells could have also contributed to the observed increases in apoptotic 
signaling after cardiotoxin exposure, as myoblast differentiation has been shown to cause 
transient increases in caspase-3 activity
98
. Future studies examining autophagic and apoptotic 
signaling should play close attention to the temporal relationship between these two processes. 
Further evidence of a cytoprotective role of autophagy after cardiotoxin injury can be 
speculated from the autophagic protein expression, calpain activity, and ROS generation data 
obtained in the current study. Although not found to be statistically significant by 2-way 
ANOVA, it appears as though ATG7, ATG4B, and LC3B-II content was slightly higher in the 
F/F
Cre
 mice on day 3 compared to the F/F mice. Increased expression of these proteins may 
suggest an elevation of autophagic induction in the F/F
Cre
 animals at this time point since ATG4 
converts pro-LC3 to LC3-I, ATG7 helps to convert LC3B-I to LC3B-II, and increased LC3B-II 
is associated with an increased number of autophagosomes
35, 99
. This increased autophagic 
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activity on day 3 may have been a compensatory response in the F/F
Cre
 mice due to the fact that 
autophagy was initially inhibited in these animals. Additionally, although again not shown to be 
statistically significant, calpain activity and ROS generation seemed to be slightly reduced in the 
F/F
Cre
 group relative to the F/F group on day 3. These results could indicate that increased 
autophagic flux in the F/F
Cre
 animals on day 3 suppressed elevations in calpain activity and ROS 
generation. 
It was interesting to see that despite a restoration of ATG7 protein in the F/F
Cre
 animals, 
the area occupied by damaged and centrally nucleated fibers in tibialis anterior cross-sections 
from these mice appeared to be elevated on day 14 post-cardiotoxin injury relative to the F/F 
mice. Although the reason for this is unknown, it is postulated that perhaps the initial 
suppression of autophagy in the F/F
Cre 
animals caused a need for increased muscle remodeling 
later in the recovery process compared to the F/F mice. Although not shown to be statistically 
significant by 2-way ANOVA, potential increases in the activity of calpain and cathepsin 
enzymes (which have both been shown to be involved with muscle remodeling)
100, 101
 in the 
F/F
Cre
 animals compared to the F/F animals on day 14 support this theory. 
Additional notable findings of the current study involved changes in fiber type 
distribution as a result of cardiotoxin exposure and potentially as a result of basal autophagy 
inhibition. Main effects of time showed a higher percentage of type IIA and IIB fibers on day 0, 
while an increased percentage of type IIA/X and IIX/B fibers was observed on day 14. The 
increase in hybrid fiber percentage on day 14 after cardiotoxin exposure likely demonstrates that 
fiber type transitions towards the basal fiber type composition were still occurring at this time 
since changes in myosin heavy chain composition occur along a continuum
102
. Cardiotoxin 
exposure also resulted in an increase in the total number of fibers in the muscle on day 14; 
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however, this was likely driven by the fact that some areas of the muscle cross-sections 
contained numerous fibers that were much smaller than normal (and likely still regenerating) at 
this time point. Interestingly, although not found to be statistically significant by 2-way 
ANOVA, a seemingly increased type IIA fiber percentage in conjunction with a seemingly 
decreased type IIB fiber percentage in the F/F
Cre
 animals on day 0  may suggest that autophagy 
inhibition under basal conditions causes a glycolytic-to-oxidative fiber type shift. Indeed, when 
autophagic function was restored in these mice on day 14, similar type IIA and IIB fiber 
distribution was observed between groups. Previous work by Moresi et al. reported a similar shift 
towards an increased proportion of oxidative fibers as a result of autophagy inhibition caused by 
HDAC1 and HDAC2 double knockout
103
. The proposed fiber type switch away from glycolytic 
type IIB fibers and towards oxidative type IIA fibers in the autophagy-deficient F/F
Cre
 mice in 
the current thesis may have been caused by the increased reliance on autophagy in glycolytic 
fibers as mentioned earlier. 
Alterations in fiber type-specific and whole muscle cross-sectional area were also 
observed between the F/F and F/F
Cre
 animals. While similar fiber type-specific cross-sectional 
areas were observed between groups in all fiber types on day 0, type IIA, IIX, and IIX/B fiber 
CSA increased on day 14 in the F/F
Cre
 mice but not in the F/F mice. Despite a lack of statistical 
significance, it seems as though type IIA/X and IIB fiber CSA was also increased in the F/F
Cre
 
animals on day 14. These increases in fiber-type specific CSA were accompanied by a statistical 
trend towards increased whole muscle cross-sectional area. While this study did not find any 
results to explain why muscle fiber hypertrophy occurred in the F/F
Cre
 group, one potential 
explanation involves insulin. Insulin is a peptide hormone that mediates the uptake of glucose 
into skeletal muscle, and also promotes protein synthesis and hypertrophy in skeletal muscle
104, 
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105
. Prior research has suggested that autophagy inhibition may promote insulin resistance and 
elevated levels of circulating insulin
73, 106-108
. Consequently, it is possible that the initial 
autophagy inhibition in the F/F
Cre
 mice led to muscle insulin resistance and increased levels of 
circulating insulin. However, upon restoration of ATG7 expression and autophagic function, the 
muscles of the F/F
Cre
 mice may have regained their sensitivity to insulin. This improved insulin 
sensitivity along with temporarily increased levels of circulating insulin may have led to muscle 
fiber hypertrophy. Nevertheless, this theory is merely speculative as no measures of insulin 
sensitivity or circulating insulin were conducted in this study. 
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Limitations 
Despite previous interesting findings in the inducible, skeletal muscle-specific Atg7 
knockdown mice, it appears as though this model (at least when Cre recombination is driven by 
the HSA promoter) is not suitable for the study of extensive muscle damage. The restoration of 
ATG7 expression in the F/F
Cre
 mice upon muscle injury was clearly a major limitation of this 
study, and it prevented truly answering the question of whether autophagy serves a 
cytoprotective or cytotoxic role in skeletal muscle. Additionally, the lower level of ATG7 
knockdown achieved in this study compared to other studies in the literature limited the ability to 
make strong conclusions regarding the effects of autophagy on the cellular environment and on 
apoptotic signaling under basal conditions. Moreover, we did not visualize possible 
abnormalities in organelle (e.g. mitochondria, sarcoplasmic reticulum) structure or sarcomere 
organization, or directly visualize autophagic flux (i.e. the formation and degradation of 
autophagosomes) under basal conditions or post-injury. The systemic administration of 
tamoxifen (i.e. via intraperitoneal injection) could also be viewed as a limitation since it may act 
on other tissues and/or have other effects independent of inducing Atg7 knockdown. However, it 
is very unlikely that the amount of tamoxifen administered in this study (2mg/day x 5 days = 
10mg) had any toxic effects as the LD50 for tamoxifen via intraperitoneal delivery has been 
shown to be ~200mg/kg in mice
109
. Furthermore, although there is a small chance that systemic 
administration of tamoxifen affected the muscle’s response to cardiotoxin-induced damage, it is 
unlikely that differences between genotypes existed since both groups were treated with 
tamoxifen. It is also unlikely that tamoxifen altered basal autophagic signaling on its own as pilot 
studies revealed similar levels of ATG7, p62, LCB-I, and LC3B-II between tamoxifen-treated 
and saline-treated F/F animals (data not shown). Another limitation of this study was that, as 
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discussed above, the expression levels of various proteins such as ATG7 that were detected by 
immunoblotting likely represented expression not only in the muscle cells but also in infiltrating 
immune cells and other cell types such as blood cells. The presence of these other cells within 
the muscle may have artificially increased various protein contents that were assumed to signify 
muscle protein expression. The use of meloxicam as an analgesic agent after cardiotoxin 
treatment also represents a limitation since meloxicam is a non-steroidal anti-inflammatory drug 
(NSAID). This may have blunted the inflammatory response to muscle damage and altered the 
autophagic and apoptotic signaling normally associated with muscle damage and regeneration. 
Notably, injections of meloxicam were only given immediately after and 24 hours post-
cardiotoxin injection (i.e. meloxicam was not administered throughout the study period). 
Additionally, it is unlikely that differences between genotypes existed since meloxicam was 
administered to both groups. Finally, the temporal evaluation of autophagic and apoptotic 
signaling was somewhat limited in this study as only 4 time points were analyzed. Conducting 
analysis on a greater number of days would further elucidate the relationship between these two 
signaling pathways after acute muscle injury. 
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Future directions 
Continuing tamoxifen treatment throughout the study protocol (i.e. after cardiotoxin 
injection until day 14) may prevent the restoration of ATG7 expression in the F/F
Cre
 mice, 
although the exact time required for tamoxifen-induced gene recombination to occur is not 
known. Therefore, short-term restoration of ATG7 may still occur despite continuous tamoxifen 
administration because of satellite cell fusion, as it may take some time before tamoxifen-
induced gene recombination occurs in these new myonuclei. After gene recombination, it would 
also take time to degrade the ATG7 protein in the muscle that was generated by the satellite 
cells/new myonuclei. In future studies, it would also be helpful if the level of Atg7 knockdown 
was greater than that achieved in the current study. Since only a reduction of ~61% in ATG7 
content was observed in the gastrocnemius on day 0, it is very possible that gene recombination 
did not take place in all of the myonuclei of the F/F
Cre
 animals. Consequently, unaffected Atg7
+/+
 
myonuclei may have still been capable of upregulating ATG7 expression in response to 
cardiotoxin damage. Increased doses of tamoxifen may help to increase the level of Atg7 
knockdown by affecting a larger proportion of the muscle nuclei. Additionally, a longer “gene 
knockdown period” prior to cardiotoxin injection may cause greater reductions in ATG7 content 
as ATG7 expression was shown to be decreased by ~87% in undamaged quadriceps which were 
analyzed on day 14 which technically represented a “gene knockdown period” of 4 weeks. 
However, the variation in ATG7 knockdown between gastrocnemius and quadriceps could 
simply represent muscle-specific differences, and allowing 4 weeks to pass prior to cardiotoxin 
treatment would decrease the acute nature of the autophagy inhibition and increase the chance 
that the muscle would make compensatory changes as an adaptation to the autophagy deficiency.  
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Another possible approach to study the interplay between autophagy and muscle damage 
in inducible Atg7 knockdown mice in the future could be to find a stress that is less intense than 
cardiotoxin. If the stress was less extreme, it is possible that less satellite cell recruitment would 
occur and in turn the inhibition of autophagy would have a greater chance to persist. Eccentric 
exercise is thought to cause muscle damage, but the damage is believed to be limited to the 
excitation-contraction system and the force-bearing structures of the muscle (e.g. z-line, myosin 
crossbridges, myotendinous junction)
110
. In fact, Warren and colleagues concluded that 
dysfunction in the excitation-contraction coupling process (i.e. the events that occur between 
acetylcholine release at the neuromuscular junction and Ca2+ release from the sarcoplasmic 
reticulum) was responsible for up to 75% of the force decrease seen after eccentric exercise, with 
the remaining force deficit being caused by alterations and/or physical disruption to the force-
bearing structures
111
. One reason for this conclusion was the fact that these authors were able to 
eliminate a 43% eccentric exercise-induced decrease in maximal isometric tetanic force by 
incubating the muscle with caffeine (which increases Ca2+ release from the sarcoplasmic 
reticulum)
111
. Additionally, Lo Verso and colleagues found no signs of major morphological 
damage (i.e. inflammation, necrosis, plasma membrane disruption) in tamoxifen-inducible, 
skeletal muscle-specific Atg7 KO mice or control mice subjected to eccentric exercise
73
. In turn, 
eccentric exercise could potentially be considered less traumatic to the muscle than cardiotoxin 
exposure. Unfortunately, despite a potentially lower level of damage, an increase in satellite cell 
activity has still been observed in response to eccentric exercise
112-114
. Another possible method 
to induce muscle damage is to expose mice to the chemotherapeutic drug doxorubicin, as a small 
amount of literature has shown that intraperitoneal injection of doxorubicin is myotoxic in rats
95, 
115. In contrast, pilot studies for the current Master’s thesis found that doxorubicin injection did 
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not lead to any visible signs of morphological damage, nor did it lead to increased activation of 
apoptotic enzymes (Appendix Figure A3, A4, A5, and A6). Consequently, the effectiveness of 
inducing muscle damage by eccentric exercise or doxorubicin administration in absence of a 
significant satellite cell response is uncertain. 
Alternatively, rather than using inducible Atg7 knockdown mice, future studies may 
consider using constitutive Atg7 knockdown animals to study the relationship between 
autophagy inhibition, apoptotic signaling, and muscle damage. Judging from the literature 
discussed earlier, it is likely that greater Atg7 knockdown and autophagy inhibition occurs in the 
constitutive Atg7 knockdown animals, and fewer myonuclei remain Atg7
+/+
. Furthermore, since 
the localization of Cre recombinase is not controlled by mutated estrogen receptors in this model, 
Cre is able to translocate freely to the nucleus and cause Atg7 deletion at all times under basal 
conditions, and could also translocate and cause gene recombination in new myonuclei after 
cardiotoxin exposure. However, as previously discussed, there are limitations with this model as 
well since the constitutive Atg7 knockdown animals could develop adaptations to the gene 
knockdown during development to compensate for the lack of autophagy. One example of such 
an adaptation is that constitutive Atg7 knockout mice studied by Masiero and colleagues 
displayed a decreased amount of centrally nucleated fibers in comparison to inducible, skeletal 
muscle-specific Atg7 knockout mice
72
. Moreover, it is speculated that some restoration of ATG7 
protein expression would be an issue in the constitutive Atg7 knockdown animals as well, at 
least for a period of time. This is because upon muscle damage, satellite cells would still be 
recruited and, like in the inducible Atg7 knockdown model, these satellite cell nuclei would still 
possess the Atg7 gene at first. Upon fusing to the damaged muscle fibers, these nuclei would 
produce the Cre recombinase enzyme necessary for gene knockdown, but would also produce 
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some ATG7 protein prior to Cre-mediated recombination of the Atg7 gene. This newly generated 
ATG7 protein could then support autophagic flux for a period of time before its natural 
degradation occurred. It is possible that the expression of ATG7 during this time would mask 
any conclusions regarding the true effects of autophagy inhibition during the initiation of muscle 
damage.  
Because of the limitations in both inducible and constitutive Atg7 knockdown animals, it 
seems as though the best way to study the relationship between autophagy inhibition, apoptotic 
signaling, and muscle damage would be to induce Atg7 knockdown in both the myonuclei and 
the satellite cells prior to injury. This could potentially be accomplished by breeding the 
inducible mice used in this study with similar inducible mice where Cre transcription is driven 
by a satellite cell-specific marker such as Pax7. However, the inhibition of autophagy in satellite 
cells may also present a problem. A study by Tang & Rando found that inhibiting autophagy in 
satellite cells using chloroquine (a lysosomal inhibitor) or 3-methyladenine (a PI3K inhibitor) 
suppressed satellite cell activation
116
. Furthermore, they found that SIRT1 (a nutrient sensor) 
regulated autophagy during satellite cell activation, and that the inhibition of autophagy due to 
sirt1 knockout in satellite cells suppressed their activation
116
. In other words, autophagy 
inhibition in satellite cells may prevent their recruitment to the muscle fibers, causing a 
regenerative issue upstream of the effects of autophagy inhibition in the muscle itself. Further 
research into the inhibition of autophagy in both satellite cells and myonuclei should be 
conducted to see if this causes a lasting suppression of autophagy upon muscle injury without 
interfering with satellite cell recruitment. 
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Conclusions 
In conclusion, although this thesis was not able to truly examine the changes in apoptotic 
signaling and muscle recovery in response to autophagy inhibition, it was able to further 
elucidate the relationship between autophagy and apoptosis after acute muscle injury. In fact, the 
results of this study seem to indicate a cytoprotective role for autophagy in response to muscle 
damage by blunting increases in cell stress and suppressing apoptotic signaling. This study also 
demonstrated that basal autophagy inhibition may alter fiber type distribution, and that a 
restoration of autophagy in previously autophagy-deficient muscle can potentially restore muscle 
fiber type composition and enhance muscle mass. Finally, this thesis discovered valuable 
methodological information for future studies as it showed that tamoxifen-inducible, skeletal 
muscle-specific knockdown models where Cre recombinase expression is driven by the HSA 
promoter should not be used in conditions of extensive muscle damage that causes satellite cell 
recruitment. Future research examining the effects of inducible gene manipulation during 
conditions of muscle damage should consider inducing a knockout in both myonuclei and 
satellite cells. 
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Appendix 
 
Figure A1: Validation of the tamoxifen-inducible, skeletal muscle-specific Atg7 knockdown model. Representative 
immunoblot two weeks post-treatment showing soleus Atg7 protein content from Atg7 F/F and Atg7 F/F
Cre
 animals 
treated with vehicle or tamoxifen (A). Representative immunoblot showing LC3B protein levels from Atg7 F/F and 
Atg7 F/F
Cre
 animals treated with vehicle or tamoxifen (B). Although there is no visible decrease in LC3B-II, the 
accumulation of LC3B-I in the Atg7 F/F
Cre
 mice suggests an inhibition of the conversion of LC3B-I to LC3B-II 
which will inhibit autophagy. Representative immunoblot showing the skeletal muscle-specific nature of Atg7 
protein knockdown in the tamoxifen-treated F/F
Cre
 mice (C). 
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Figure A2: Body weight and absolute muscle weights on day 14. Quantification of body weight (A), absolute TA 
(B), gastrocnemius (C), soleus (D), and plantaris (E) muscle weights (n=8 per group). No significant differences 
were observed by Student’s t-tests.  
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Figure A3: Apoptotic enzyme activity in C57 mice in response to doxorubicin exposure (n=3 per day). Days 
listed represent the number of days after doxorubicin treatment, with day 0 being a basal measurement prior to 
injection. No significant increases in apoptotic enzyme activities were observed in gastrocnemius on any day 
relative to day 0.  
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Figure A4: Morphological analysis of muscle damage in response to doxorubicin treatment. Days listed represent 
the number of days after doxorubicin treatment, with day 0 being a basal measurement prior to injection. No major 
differences in morphology were observed at any time point compared to day 0. Sol: soleus. Plant: plantaris. 
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Figure A5: Apoptotic enzyme activity of F/F and F/F
Cre
 mice treated with both tamoxifen and doxorubicin (n=4 per 
group). All mice were sacrificed 4 days after doxorubicin injection in an attempt to allow enough time for 
doxorubicin to cause muscle damage. No differences in apoptotic enzyme activities were observed between the F/F 
and F/F
Cre
 (autophagy deficient) mice. RG: red gastrocnemius. WG: white gastrocnemius.   
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Figure A6: Morphological analysis of muscle damage in F/F and F/F
Cre
 mice treated with both tamoxifen and 
doxorubicin. All mice were sacrificed 4 days after doxorubicin injection in an attempt to allow enough time for 
doxorubicin to cause muscle damage. No major differences in morphology were observed between the F/F and 
F/F
Cre
 (autophagy deficient) mice. Sol: soleus. Plant: plantaris. 
